J Orthop Sports Phys Ther. Author manuscript; available in PMC 2014 Mar 24.

Published in final edited form as:

J Orthop Sports Phys Ther. 2009 Apr; 39(4): A1–25.

doi:  10.2519/jospt.2009.0301

PMCID: PMC3963282

NIHMSID: NIHMS561090

Hip Pain and Mobility Deficits – Hip Osteoarthritis

Clinical Practice Guidelines Linked to the International Classification of Functioning, Disability, and Health from the Orthopaedic Section of the American Physical Therapy Association

Michael T. Cibulka, DPT, Douglas M. White, DPT, Judith Woehrle, PT, PhD, Marcie Harris-Hayes, DPT, Keelan Enseki, PT, MS, Timothy L. Fagerson, DPT, MS, James Slover, MD, MS, and Joseph J. Godges, DPT

Author information ► Copyright and License information ►

The publisher's final edited version of this article is available at J Orthop Sports Phys Ther

See other articles in PMC that cite the published article.

Go to:

Introduction

AIM OF THE GUIDELINE

The Orthopaedic Section of the American Physical Therapy Association (APTA) has an ongoing effort to create evidence-based practice guidelines for orthopaedic physical therapy management of patients with musculoskeletal impairments described in the World Health Organization's International Classification of Functioning, Disability, and Health (ICF).210

The purposes of these clinical guidelines are to:

• Describe evidence-based physical therapy practice including diagnosis, prognosis, intervention, and assessment of outcome for musculoskeletal disorders commonly managed by orthopaedic physical therapists
• Classify and define common musculoskeletal conditions using the World Health Organization's terminology related to impairments of body function and body structure, activity limitations, and participation restrictions
• Identify interventions supported by current best evidence to address impairments of body function and structure, activity limitations, and participation restrictions associated with common musculoskeletal conditions
• Identify appropriate outcome measures to assess changes resulting from physical therapy interventions in body function and structure as well as in activity and participation of the individual
• Provide a description to policy makers, using internationally accepted terminology, of the practice of orthopaedic physical therapists
• Provide information for payors and claims reviewers regarding the practice of orthopaedic physical therapy for common musculoskeletal conditions
• Create a reference publication for orthopaedic physical therapy clinicians, academic instructors, clinical instructors, students, interns, residents, and fellows regarding the best current practice of orthopaedic physical therapy

STATEMENT OF INTENT

This guideline is not intended to be construed or to serve as a standard of medical care. Standards of care are determined on the basis of all clinical data available for an individual patient and are subject to change as scientific knowledge and technology advance and patterns of care evolve. These parameters of practice should be considered guidelines only. Adherence to them will not ensure a successful outcome in every patient, nor should they be construed as including all proper methods of care or excluding other acceptable methods of care aimed at the same results. The ultimate judgment regarding a particular clinical procedure or treatment plan must be made in light of the clinical data presented by the patient, the diagnostic and treatment options available, and the patient's values, expectations, and preferences. However, we suggest the rationale for significant departures from accepted guidelines be documented in the patient's medical records at the time the relevant clinical decision is made.

Go to:

Methods

The Orthopaedic Section, APTA appointed content experts as developers and authors of clinical practice guidelines for musculoskeletal conditions of the hip which are commonly treated by physical therapists. These content experts were given the task to identify impairments of body function and structure, activity limitations, and participation restrictions, described using ICF terminology, which could (1) categorize patients into mutually exclusive impairment patterns upon which to base intervention strategies, and (2) serve as measures of changes in function over the course of an episode of care. The second task given to the content experts was to describe the supporting evidence for the identified impairment pattern classification as well as interventions for patients with activity limitations and impairments of body function and structure consistent with the identified impairment pattern classification. It was also acknowledged by the Orthopaedic Section, APTA content experts that a systematic search and review of the evidence solely related to diagnostic categories based on International Statistical Classification of Diseases and Related Health Problems (ICD)209 terminology would not be useful for these ICF-based clinical practice guidelines as most of the evidence associated with changes in levels of impairment or function in homogeneous populations is not readily searchable using the ICD terminology.

The authors of this guideline (M.T.C., D.M.W., J.W.) independently performed a systematic search of the MEDLINE, CINAHL, and the Cochrane Database of Systematic Reviews (1967 through August 2008) for any relevant articles related to classification, examination, and intervention for musculoskeletal conditions of the hip region commonly treated by physical therapists. As relevant articles were identified, their reference lists were hand-searched in an attempt to identify additional articles that might contribute to the outcome of this guideline. Articles from the searches were compiled by 3 of the authors (M.T.C., D.M.W., J.W.) and this compilation was reviewed for accuracy and completeness by 3 other authors (M.H.H., K.E., T.L.F.). Articles with the highest levels of evidence that were most relevant to classification, examination, and intervention for patients with hip pain, mobility deficits, and osteoarthritis (OA) were included in this guideline.

This guideline was issued in 2009 based upon publications in the scientific literature prior to September 2008. This guideline will be considered for review in 2013, or sooner if new evidence becomes available. Any updates to the guideline in the interim period will be noted on the Orthopaedic Section of the APTA website: www.orthopt.org

LEVELS OF EVIDENCE

Individual clinical research articles were graded according to criteria described by the Center for Evidence-Based Medicine, Oxford, United Kingdom (Table 1, below).

Table 1

GRADES OF EVIDENCE

The overall stretchy of the evidence supporting recommendations made in this guideline were graded according to guidelines described by Guyatt et al,75 as modified by MacDermid and adopted by the coordinator and reviewers of this project. In this modified system, the typical A, B, C, and D grades of evidence have been modified to included the role of consensus expert opinion and basic science research to demonstrate biological or biomechanical plausibility (Table 2, below).

Table 2

REVIEW PROCESS

The Orthopaedic Section, APTA also selected consultants from the following areas to serve as reviewers of the early drafts of this clinical practice guideline:

• Arthritis Foundation
• Claims review
• Coding
• Epidemiology
• Rheumatology
• Section on Geriatrics of the APTA
• Medical practice guidelines
• Orthopaedic physical therapy residency education
• Physical therapy academic education
• Sports physical therapy residency education

Comments from these reviewers were utilized by the authors to edit this clinical practice guideline prior to submitting it for publication to the Journal of Orthopaedic & Sports Physical Therapy.

In addition, several physical therapists practicing in orthopaedic and sports physical therapy settings were sent initial drafts of this clinical practice guideline along with feedback forms to determine its usefulness, validity, and impact. All returned feedback forms from these practicing clinicians described this clinical practice guideline as:

• “Moderately useful” or “extremely useful”
• An “accurate representation of the peer-reviewed literature”
• A guideline that will have a “substantial positive impact on orthopaedic physical therapy patient care”

CLASSIFICATION

The primary ICD-10 code and condition associated with hip pain and mobility deficits is M16.1 Primary coxarthrosis, unilateral. In the ICD, the term osteoarthritis (OA) is used as a synonym for arthrosis or osteoarthrosis. Other, secondary codes associated with hip OA are M16.0 Primary coxarthrosis, bilateral; M16.2 Coxarthrosis resulting from dysplasia, bilateral; M16.3 Dysplastic coxarthrosis, unilateral; M16.4 Posttraumatic coxarthrosis, bilateral; M16.5 Posttraumatic coxarthrosis, unilateral; M16.7 Secondary coxarthrosis, not otherwise specified. The corresponding ICD-9 CM codes and conditions, which are used in the USA, are 715.15 Osteoarthrosis of the pelvic region and thigh, localized, primary; 715.25 Osteoarthrosis of the pelvic region and thigh, localized, secondary; 715.85 Osteoarthrosis of the pelvic region and thigh involving more than 1 site but not specified as generalized.

The primary ICF body function codes associated with the above noted primary ICD-10 condition are the sensory functions related to pain and the movement-related functions related to joint mobility. These body function codes are b2816 Pain in joints and b7100 Mobility of a single joint.

The primary ICF body structure codes associated with hip pain and mobility deficits are s75001 Hip joint, s7402 Muscles of pelvic region, and s7403 Ligaments and fascia of pelvic region.

The primary ICF activities and participation codes associated with hip pain and mobility deficits are d4154 Maintaining a standing position, d4500 Walking short distances, and d4501 Walking long distances.

The ICD-10 and primary and secondary ICF codes associated with hip pain and mobility de.cits are provided in Table 3 on the facing page.

Table 3

ICD-10 and ICF Codes Associated With Hip Pain and Mobility Deficits

Go to:

CLINICAL GUIDELINES

Impairment/Function-based Diagnosis

PREVALENCE

Hip pain associated with OA is the most common cause of hip pain in older adults.7, 40Prevalence studies have shown the rates for adult hip OA range from 0.4% to 27%.8,40,74,89,126,211

PATHOANATOMICAL FEATURES

The proximal femur articulates with the acetabulum to form the hip joint. The femoral head is two thirds of a sphere covered with hyaline cartilage and enclosed in a fibrous capsule.50,168 The femoral head is connected to the femoral shaft via the femoral neck. In the frontal plane the femoral neck lies at an angle to the shaft of the femur. This “angle of inclination” is normally 120° to 125° in the adult population.50 In the transverse plane the proximal femur is oriented anterior to the distal femoral condyles as a result of a medial torsion of the femur with a normal range between 14° to 18° of anteversion.28 The hip joint is a “ball and socket” synovial joint with articular cartilage and a fully developed joint capsule allowing movement in all 3 body planes.168 The joint capsule attaches around the acetabular rim proximally and distally at the inter-trochanteric line. Three strong ligaments reinforce the joint capsule, the iliofemoral and pubofemoral ligaments anteriorly and ischiofemoral ligament posteriorly.50

 In OA of the hip the entire joint structure and function is affected, with joint capsular changes (shortening and lengthening) creating limitation in hip joint range of motion (ROM) along with subsequent articular cartilage degeneration.120,148 Later in the disease process osteophytes or spurs may develop from excessive tensile force on the hip joint capsule or from abnormal pressure on the articular cartilage.6,120Other changes also develop including sclerosis of the subchondral bone from increased focal pressure, and sometimes the formation of cysts.98 Muscle weakness often develops around a joint with OA,171 specifically the abductor muscles of the hip.156 Most significantly, the hip abductor muscles progressively weaken in the later stages of hip OA, which may create a Trendelenberg gait pattern over time.11 Clinicians must not overlook the function of the hip muscles at different hip positions, for example the gluteus medius is an abductor when at 0° of flexion (standing) but an external rotator at 90° of flexion (sitting).129

 Clinicians should assess for impairments in the mobility of the hip joint and the strength of the surrounding muscles, especially the hip abductor muscles, when a patient presents with hip pain.

RISK FACTORS

 Age the most common predisposing factor for hip OA is age. The condition primarily affects middle-aged and elderly people, most often those over 60 years.2, 154, 177 Tepper and Hochberg177 found that age was significantly associated with hip OA (adjusted odds ratio of 1.30 (95% CI: 0.60–2.81) for ages 60 to 64 years, 2.38 (95% CI: 0.83–3.44) for ages 65 to 69 years, and 2.38 (95% CI: 1.15–4.92) for ages 70 to 74 years.

 Developmental Disorders Many studies have demonstrated a link between developmental disorders, such as Legg-Calve-Perthes disease, congenital hip dislocation, or slipped capital femoral epiphysis, and premature OA of the hip.1, 61, 62, 91, 92, 139, 214 The majority of the evidence also shows that dysplasia of the femur and the acetabulum is associated with hip OA.49, 52, 92, 94, 162, 178, 185–188 Dysplasia is defined as any change in orientation of the acetabulum or the proximal femur, which creates a change in how the femur and the acetabulum articulate with each other.93 Types of dysplasia include coxa vara, coxa valga, femoral anteversion, femoral retroversion, acetabular anteversion, acetabular retroversion, coxaplana, and coxaprofundus.20, 92, 93 However, a few authors show limited association between hip dysplasia and OA of the hip.20, 90, 108, 207

 Race Studies of non-Caucasian populations including Asian, African, and East Indian populations indicate a very low prevalence of primary hip OA when compared to that of Caucasians of European ancestry.81, 211 Thus, race likely plays some sort of role in the development of hip OA. This role, however, is unknown at this time.

 Gender Few studies have been performed that examine the association between gender and hip OA.41, 97, 145, 154 Tepper and Hochberg177 found that males have a slightly greater prevalence of hip OA compared to females (3.2% compared to 3.0%). Although little if any difference in incidence exists between genders, men and women appear to have different patterns of hip OA. Women have a more superiomedial femoral migration while men have a more superiolateral migration.44, 111 There is strong evidence that superiolateral migration is an important prognostic factor in the progression of hip OA.15

 Genetics Siblings show a high association of hip OA, suggesting a possible genetic role.109While the nature of the genetic influence is still speculative, it has been postulated that hip OA involves either a structural defect (ie, collagen) or alterations in cartilage or bone metabolism.106, 121, 122 Genetics is often linked to hip OA because of the low prevalence of hip OA in Asian and African populations in their native countries and the familial association of hip OA in Caucasians.81 Some studies have shown that genetic factors may play a role in the development of hip OA,100, 106, 124 or in reducing the risk of hip OA in women.113 Although there has been much interest and speculation in looking for a genetic link to hip OA, currently there is insufficient evidence to explain how genetics is related to the development of hip OA.

 Occupation Numerous researchers in Europe and the United States have found a higher prevalence of hip OA in male workers whose occupation involved lifting very heavy loads over a prolonged period.125, 201, 203, 204 Farming, in particular, has been identified as a high-risk occupation for the development of hip OA. However, a specific aspect of farming which leads to the development of hip OA has not been identified. Suspected risk factors have been suggested, including regular heavy lifting, tractor driving (vibration), and walking on uneven ground.36, 84, 125, 179–182, 208 Vibration was specifically studied and reported to not be associated with the development of hip OA.96 In summary, there is weak evidence linking the development of hip OA to some occupations.114

 Sports Exposure Epidemiological studies have demonstrated participation in certain competitive sports to increase the risk for OA.25, 115 Running has low risk for OA,107 but high-intensity, direct-impact activities, such as American football and hockey, appear to increase the risk of hip OA.24, 25

 Previous Injury Proximal hip fracture results in changes to the articular surfaces of the hip joint that creates abnormal joint load bearing and has been shown to be related to the development of hip OA.60 A history of a previous hip injury is also associated with hip OA.35, 177 Cooper et al35 reported an odds ratio for hip OA when having a previous hip injury of 4.3 (95% CI: 2.2–8.4). In addition, patients with OA of 1 hip are at increased risk of developing OA in the opposite hip.206

 Body Mass Index A few studies have shown body mass index (BMI) to be related to hip OA.35,116, 200 Other studies, however, have shown little to no association between hip OA and BMI.59, 73, 92, 95,117 The most current evidence shows BMI is not related to hip OA.161 What seems apparent is that obesity is probably associated with the progression of hip OA rather than onset,127 and the therapeutic value of weight loss is important.52, 202

 Leg Length Disparity Several studies have suggested that a difference in leg lengths may be an important etiological factor in hip OA.63–65, 68, 140 A few studies have demonstrated the biomechanical and clinical problem of leg length disparity and its relationship to hip OA.63–65 Nahoda141 reported on the importance of correcting leg length disparity in the prevention of hip OA. Golightly68 noted an association between radiographic hip OA and leg length disparity. A few papers on leg length disparity suggest a relationship with hip OA; however, more research is needed before leg length disparity can be considered an important risk factor. It should be pointed out that leg length disparity could also occur as a result of OA of the hip, particularly when there is superior migration of the femoral head in the acetabulum.

 Clinicians should consider age, hip developmental disorders, and previous hip joint injury as risk factors for hip osteoarthritis.

NATURAL HISTORY

The natural history of individual hip OA is imperfectly understood. Many different factors contribute to this. The clinical manifestations that develop in patients with hip OA include changes in the shape, density, length, and function of the bones, cartilage, and fibrous tissue surrounding the hip joint itself as well as the surrounding muscles. The changes that occur around the arthritic hip include a decrease in the joint space between the femur and acetabulum (more common superior and lateral than medial), shortening of the fibrous joint capsule, flattening of the femoral head, the appearance of osteophytic growth around the margins of the femoral head and acetabulum (in some individuals boney overgrowth does not occur), a superior-lateral or medial migration of the femoral head, and the development of subchondral sclerosis or cysts in the femoral head and ac-etabulum.4, 6, 42, 72, 98, 167 Changes that occur outside of the hip joint include a decreased amount of hip joint ROM (usually mostly affecting internal rotation and then flexion) and muscle weakness (particularly the abductor muscles), which eventually may result in difficulty with ambulation.7, 116, 118, 148 The progression of these changes are usually slow but may be quite rapid in some cases.21 Currently, there is no reliable, generally accepted classification of the stages or severity of hip OA and the rate of progression varies from patient to patient, even when the demographics of the patients are similar.7

DIAGNOSIS/CLASSIFICATION

 The diagnosis of hip OA can be made with a reasonable level of certainty on the basis of the history and physical examination.2, 16 Joint space narrowing along with other radiographic features including osteophytes and subchondral sclerosis on plain film radiographs is considered the definitive diagnosis.6, 19, 37, 42, 45 The following clinical criteria are typically present in individuals who have radiographic findings consistent with hip OA.2, 16, 18

• Reports of moderate pain in the lateral or anterior hip with weight bearing. This pain may progress to the anterior thigh or knee region
• Adults, greater than 50 years of age
• Limited passive hip joint ROM in at least 2 of its 6 directions (flexion, extension, abduction, adduction, internal rotation, and external rotation)
• Morning stiffness, which improves in less than 1 hour

 Clinical criteria for the classification of patients with hip pain associated with OA were developed through a multicenter study by the American College of Rheumatology.2 One hundred fourteen patients, with a mean age of 64 years and 87 controls with a mean age of 57 years, were included in the study. Patients were classified as having hip OA if they (1) reported experiencing hip pain, and (2) presented with either one of the following clusters of clinical findings:

• Hip internal rotation less than 15°, along with
• Hip flexion less than or equal to 115°
• Age greater than 50 years

Or,

• Hip internal rotation greater than or equal to 15°, along with
• Pain with hip internal rotation
• Duration of morning stiffness of the hip less than or equal to 60 minutes
• Age greater than 50 years

When patients were classified using these clinical criteria compared to a radiographic reference standard of joint space narrowing and osteophytes, the following diagnostic accuracy statistics were reported: sensitivity, 86%; specificity, 75%; positive likelihood ratio (LR+), 3.44; negative likelihood ratio (LR−), 0.19.2

Hip OA is classified as primary in the absence of any obvious underlying joint abnormality, or secondary if degeneration occurs as a result of a pre-existing abnormal joint problem.81 Some suggest that all hip OA is secondary to some pre-existing problem (eg, dysplasia).119 The clinical and/or radiological criteria presented above are usually sufficient to diagnose a patient with OA of the hip and the associated ICF impairment-based category of hip pain (b2816 Pain in joints) and mobility deficits (b7100 Mobility of a single joint).

 A recent preliminary study of patients with hip symptoms identified 5 possible clinical predictors for diagnosis: pain aggravated with squatting, lateral or anterior hip pain with the scour test, active hip flexion causing lateral hip pain, pain with active hip extension, and passive range of hip internal rotation less than 25°.175 The LR+ of having hip OA when all 5 predictors were present was 7.3, while the LR- was .87.175One limitation of this study was the small sample of patients (21 of 79) who had hip OA on radiographs. This could have resulted in spurious findings. Future studies are needed to validate these results prior to clinical use.

 Birrell et al18, 19, 20 also used a standard clinical and radiographic examination to assess the predictability of hip OA from hip ROM. In their study, 195 patients with recent onset of hip pain with radiographic evidence of OA had restricted movement at the hip compared with those without radiographic evidence of hip OA. Restriction in internal rotation was the most predictive and flexion the least predictive of radiographic OA. When comparing sides, a ROM difference of more than 15° between the painful and nonpainful side was considered a limitation of joint mobility. Restriction in hip ROM was predictive of the presence of OA. The diagnostic accuracy for restriction in a single plane of hip motion for patients with severe hip OA was as follows: sensitivity, 100%; specificity, 54%; LR+, 2.17; LR-, 0.01. The diagnostic accuracy for restriction in a single plane of hip motion for patients with moderate hip OA was the following: sensitivity, 86%; specificity, 42%; LR+, 1.48; LR−, 0.33. The diagnostic accuracy for restriction in all 3 planes of hip motion for patients with moderate hip OA was: sensitivity, 33%; specificity, 98%; LR+, 16.5; LR−, 0.67. 2, 16, 18

 Moderate lateral or anterior hip pain during weight bearing, in adults over the age of 50 years, with morning stiffness less than 1 hour, with limited hip internal rotation and hip flexion by more than 15°, when comparing the painful to the nonpainful side, are useful clinical findings to classify a patient with hip pain into the International Statistical Classification of Diseases and Related Health Problems (ICD) category of unilateral coxarthrosis and the associated International Classification of Functioning, Disability, and Health (ICF) impairment-based category of hip pain (b2816 Pain in joints) and mobility deficits (b7100 Mobility of a single joint).

DIFFERENTIAL DIAGNOSIS

 The following differential diagnoses should be considered in an individual with signs or symptoms suggestive of hip OA:

• Bursitis or tendinitis
• Chondral damage or loose bodies
• Femoral neck or pubic ramus stress fracture
• Labraltear
• Muscle strain
• Neoplasm
• Osteonecrosis of the femoral head
• Paget's disease
• Piriformis syndrome
• Psoriatic arthritis
• Rheumatoid arthritis
• Sacroiliac joint dysfunction
• Septic hip arthritis
• Referred pain as a result of an L2-3 radiculopathy

The following physical examination measures may be helpful in the differential diagnostic process when differentiating hip pain from other sources of pain:

• The Scour test for labral tears175
• FABER (Patrick's) test for labral tears137
• Fitzgerald's test for labral tears54
• Flexion-adduction internal rotation tests for labral tears112
• Sacroiliac joint provocation tests for sacroiliac joint pain110
• Femoral nerve stretch test for L2-3 radiculopathy184

 Clinicians should consider diagnostic classifications other than osteoarthritis of the hip when the patient's history, reported activity limitations, or impairments of body function and structure are not consistent with those presented in the diagnosis/classification section of this guideline, or, when the patient's symptoms are not diminishing with interventions aimed at normalization of the patient's impairments of body function.

IMAGING STUDIES

Imaging studies, specifically plain film radiographs, are confirmatory for moderate to severe hip joint OA; however, radiographs are less useful in demonstrating early os-teoarthriticjoint changes.53, 98 Joint space narrowing detected on radiographs may be a relatively late stage phenomenon of OA.23 Joint space narrowing has been advocated as the best indicator and best predictor of arthritic change in patients with hip OA, with joint space narrowing occurring more su-periolateral than superiomedial.37, 42,45 The normal hip joint space is 3 to 5 mm. A reduction of greater than or equal to 0.5 mm represents a clinically relevant and significant reduction in joint space width.4 Hip joint OA is considered moderate when joint space is less than 2.5 mm and severe when joint space is less than 1.5 mm.16 The development of newer imaging techniques, such as gadolinium enhanced magnetic resonance imaging, has been suggested as a method to detect deficiencies in cartilage structure that may represent early arthritic changes in young patients.103

In addition to joint space narrowing, other criteria, including osteophytic spurs and subchondral sclerosis, also are used to identify patients with hip OA.6, 19 The Kellgren/Lawrence scale has been used to classify degenerative findings associated with hip OA. The scale consists of 4 grades: grade 1, no radiographic evidence of OA; grade 2, doubtful narrowing of joint space and possible (minute) osteophytes; grade 3, moderate definite osteophytes, definite moderate narrowing of joint space; grade 4, large osteophytes, severe joint space narrowing, subchondral sclerosis, and definite deformity of bone contour.99 A potential caveat when using the Kellgren/ Lawrence scale is spurs or osteophytes are emphasized138, 144 and not all patients with hip OA have osteophytes.

Go to:

CLINICAL GUIDELINES

Examination

OUTCOME MEASURES

 The most commonly used outcome measure for hip OA is the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC).14 The WOMAC has been validated and its reliability has been shown in many different studies and in many different countries.12, 169, 183, 198,212 The ordinal-scale version of the index consists of 24 questions (5 about pain, 2 about stiffness, and 17 about physical function), which are assigned a score of between 0 (extreme) and 4 (none). Individual question scores are then summed to form a raw score ranging from 0 (best) to 96 (worst). Finally, raw scores are normalized by multiplying the raw score by 100/96, creating a score of between 0% (best) to 100% (worst). Test-retest reliability of the WOMAC as measured by intraclass correlation coefficients (ICCs) has been shown to be good, ranging between 0.74 and 0.89.166 The minimal clinically important difference (MCID) for the WOMAC score, as a change from the baseline score, has been reported in the range of 12% to 22%.9, 10, 46 Angst el al9 found the MCID for improvement in a sample of 192 patients with lower extremity OA to be in the range of 17% to 22% change from the baseline score. A prospective cohort study consisting of 122 patients diagnosed with hip or knee OA from an inpatient rehabilitation clinic found a 12% change from the baseline score as the MCID for the WOMAC.10

 The Lower Extremity Functional Scale (LEFS) is another reliable and valid outcome measure that is often administered to patients with hip OA.17

The LEFS uses an ordinal scale from 0 (“extreme difficulty or unable to perform the activity”) to 4 (“no difficulty”) for the patient to rate the ability to perform 20 different activities, such as getting into or out of the bath tub, sitting for 1 hour, squatting, and rolling over in bed. The total score ranges from 0 to 80, with 80 representing maximum function based on the scale. The reliability and validity of the LEFS have been shown to be good when determined using a sample of 107 patients with lower extremity mus-culoskeletal problems. In that same study, the minimum detectable change (MDC90) and MCID90 were both 9 scale points.17

 Another often used functional outcome measure is the Harris Hip Score.77 The Harris Hip Score is derived from scoring 10 different variables, including pain, ROM, gait/limp, gait distance, function, activities of daily living, and deformity. Scores range from 0 (worst) to 100 (best).77

 Clinicians should use validated functional outcome measures, such as the Western Ontario and McMaster Universities Osteoarthritis Index, the Lower Extremity Functional Scale, and the Harris Hip Score before and after interventions intended to alleviate the impairments of body function and structure, activity limitations, and participation restrictions associated with hip osteoarthritis.

ACTIVITY LIMITATION AND PARTICIPATION RESTRICTION MEASURES

6-Minute Walk Test
ICF category	Measurement of activity limitation: walking long distances
Description	A physical performance measure which assesses how far a person can walk in 6 minutes48
Measurement method	During the performance of the 6-minute walk test (6MWT), patients are instructed to cover as much distance as possible during the 6-minute time frame, with the opportunity to stop and rest if required. The test is conducted on an unobstructed level surface. The course is marked off in meters, and the distance traveled by each subject is measured to the nearest meter. Standardized verbal encouragement, “You are doing well, keep up the good work” is provided at 60-second intervals. Patients are permitted to use their regular walking aids if needed.102
Nature of variable	Continuous
Units of measurement	Meters
Measurement properties	The 6MWT showed high test-retest reliability (ICC2,1 of 0.95–0.97).170 Kennedy et al102 also showed high test-retest reliability for the 6MWT with ICC2,1 of 0.94 (95% CI: 0.88–0.98). The MDC90 for the 6MWT determined from a sample of 150 subjects with hip and knee OA, of which 69 underwent total hip arthroplasty (THA) was 61.34 m.102

Self-Paced Walk Test
ICF category	Measurement of activity limitation: walking short distances
Description	A physical performance measure which assesses how fast a person can walk for 4 m and for 40 m
Measurement method	During the performance of the self-paced walk test (SPWT), patients are instructed to “walk as quickly as you can without overexerting yourself” and timed with a stopwatch while they walk 2 lengths (turn excluded) of a 20-m indoor course102
Nature of variable	Continuous
Units of measurement	Seconds
Measurement properties	The test-retest reliability of the SPWT for 40 m has been examined by Kennedy et al.102 They found an ICC of 0.91 (95% CI: 0.81–0.97). Kennedy et al102 also showed the SPWT was responsive in detecting deterioration and improvement in the early postoperative period following arthroplasty. The MDC90 for the 40-m SPWT determined from a sample of 150 subjects with hip and knee OA of which 69 underwent THA was 4.04 seconds.102 In a cohort of 492 older adults the recommended criterion for substantial meaningful change for gait speed at 10 ft, 4 m, and 10 m was 0.1 m/s.149

Stair Measure
ICF category	Measurement of activity limitation: climbing
Description	A physical performance measure, which assesses how well a person, can ascend and descend a flight of stairs
Measurement method	During the performance of the stair measure (SM) patients are instructed to ascend and descend 9 steps (step height, 20 cm) in their usual manner, and at a safe and comfortable pace102
Nature of variable	Continuous
Units of measurement	Seconds
Measurement properties	The test-retest reliability of the SM has been examined by Kennedy et al.102 They found an ICC of 0.90 (95% CI: 0.79–0.96).102 Kennedy et al102 also showed the SM to be responsive in detecting deterioration and improvement in the early postoperative period following arthroplasty. The MDC90 for the SM, determined from a sample of 150 subjects with hip and knee OA, of which 69 underwent THA, was 5.5 seconds.102

Timed Up-and-Go Test
ICF category	Measurement of activity limitations: getting in an out of a seated position, walking short distances
Description	A physical performance measure which assesses how well a person can get up from a chair with arm rests, walk a short distance (3 m), turn around, return, and then sit down again128
Measurement method	During the performance of the timed up-and-go test (TUG), the patient sits in a chair with arm rests and is asked to stand up from the chair and walk as quickly and safely as possible to a cone 3 m away, turn, walk back to the chair, and sit down again. The performance of this test is timed.
Nature of variable	Continuous
Units of measurement	Seconds
Measurement properties	There was good agreement among observers on the subjective scoring of the TUG, and good correlation with the Berg balance scale, gait speed, Barthel’s Index of activities of daily living, and predicted patient’s ability to walk outside safely.151 Podsiadlo151 showed that the TUG had good intertester and intratester reliability (ICC = 0.99). Steffen et al170 also showed the TUG had high test-retest reliability (ICC2,1 = .95–.97). Podsiadlo151 provided evidence for the criterion-related validity of the TUG by showing it correlates well with other functional scales. Kennedy et al102 showed the TUG was responsive in detecting deterioration and improvement in postoperative time period following arthroplasty. The MDC90 for the TUG, determined from a sample of 150 subjects with hip and knee OA, of which 69 underwent THA, was 2.5 seconds.102

PHYSICAL IMPAIRMENT MEASURES

Passive Hip Internal and External Rotation and Hip Flexion
ICF category	Measurement of impairment of body function: mobility of a single joint
Description	The amount of passive hip rotation and passive hip flexion measured prone and supine, respectively. Although assessing the range in all 6 directions (3 planes) of hip motion is important in patients with hip OA, for brevity, we included the 3 most commonly limited hip motions. The patient is also asked to rate the amount of pain experienced during the movement on a 0-to-10 numerical pain rating scale (NPRS).
Measurement method	Hip Internal and External Rotation: The patient is positioned prone with feet over the edge of the treatment table. The hip measured is placed in 0° of abduction, and the contralateral hip is placed in about 30° of abduction. The reference knee is flexed to 90°, and the lower extremity is passively moved to produce hip rotation. The movement arm of the goniometer is aligned vertically along the shaft of the tibia while the stationary arm is aligned along an imaginary vertical line. Manual stabilization is applied to the pelvis to prevent pelvic movement and also at the tibiofemoral joint to prevent motion (rotation or abduction/adduction), which could be construed as hip rotation.78 The tibia is then moved in the frontal plane to produce hip internal and external rotation. The motion is stopped and measurements taken when the extremity achieves its end range of passive hip rotation or when pelvic movement is necessary for additional movement of the lower extremity. An inclinometer may also be used to measure hip rotation. The inclinometer is first “calibrated” by placing it along the distal shaft of the vertically aligned tibia, just proximal to the medial malleolus and then setting the inclinometer dial to zero. Then, the extremity is passively moved to produce hip rotation and inclinometer measure is taken when the hip achieves its end range of passive internal and external rotation.47 Hip Flexion: With the patient in the supine position, the hip is passively flexed with the movement arm of the goniometer along the long axis of the femur and the stationary arm of the goniometer along the long axis of the trunk, while stabilizing the lumbar spine to avoid any posterior pelvic tilt.83
Nature of variable	Continuous (ROM) and ordinal (pain)
Units of measurement	Degrees and 0-to-10 NPRS
Measurement properties	Limited ROM is associated with high levels of disability in patients with hip OA.172 The reliability for hip rotation and hip flexion ROM measurements has been shown to be excellent, ICC of 0.95 to 0.9747for rotation and ICC of 0.94 (95% CI: 0.89–0.97)30 for flexion. ROM measurements in 22 individuals with hip OA demonstrated excellent intrarater test-retest reliability (ICC = .97) for hip flexion.152 Croft et al38 showed good agreement among 6 testers when assessing for hip rotation and hip flexion in patients with hip OA. Steultjens et al172 also showed good reliability when assessing the hip joint in patients with OA. The MDC95 for hip flexion, determined using 22 patients with knee OA and 17 subjects without lower extremity symptoms or known pathology, is 5°, meaning any change more than 5° is considered to be change beyond measurement error.30 The MDC95 for pain with hip flexion is 1.2 on the 0–10 NPRS.30 The clinically important difference for the NPRS, derived from patients with low back pain, has been shown to be a reduction of 2 points.27,51

Hip Abductor Muscles Strength Test
ICF category	Measurement of impairment of body function: power of isolated muscles and muscle groups
Description	A test to determine the strength of the hip abductor muscles
Measurement method	The hip abductor muscles strength test is performed with the subject in the supine position and the hip in a neutral position of flexion/extension, abduction/adduction, and external/internal rotation. A “make” test using a handheld dynamometer is used by asking the subject to push the most they can against the handheld dynamometer applied on the lateral aspect of the distal thigh, just above the knee. The hip abductor muscles may also be tested in the side lying position with the hip in abduction and slight extension. A “break” test is performed by the tester applying force via the handheld dynamometer applied on the lateral aspect of the distal thigh just above the knee. The direction of force application is toward adduction and slight flexion while the pelvis is stabilized with the other hand.101
Nature of variable	Continuous
Units of measurement	Force in Newtons
Measurement properties	Interrater and intrarater reliability of force measurements obtained from college age women we re excel lent using a handheld dynamometer for the abductor muscles (intrarater ICC, .88–.96; interrater ICC, .90–.95).31 Force measurements of hip abductors in 22 individuals with hip OA demonstrated good intrarater test-retest reliability (ICC of .84).152 The MDC95, determined from a sample of 90 subjects (age range, 22–70 years) without any previous musculoskeletal problems, was 5.4% of body weight for males and 5.3% of body weight for females.213

The FABER (Patrick’s) Test
ICF category	Measurement of impairment of body function: pain in joints
Description	A test to determine the irritability of the hip joint
Measurement method	The FABER test is administered with the subject in supine, the heel of the lower extremity to be tested placed over the opposite knee. The hip joint is passively externally rotated and abducted by the examiner applying manual pressure over the ipsilateral knee, while stabilizing the contralateral innominate with the opposite hand. After being zeroed against a wall, the inclinometer is placed on the medial aspect of the tibia of the tested lower extremity, just distal to the medial tibial condyle. ROM measurement is taken at the point of maximal passive resistance or at the point where the patient stops the test secondary to pain.30The patient is also asked to rate the location of the pain as well as the amount of pain experienced during the movement on a 0-to-10 NPRS.
Nature of variable	Continuous (ROM) and ordinal (pain)
Units of measurement	0-to-10 NPRS
Measurement properties	Intrarater reliability of ROM (ICC = 0.96; 95% CI: 0.92–0.98) and pain (ICC = 0.87; 95% CI: 0.78–0.94) measurements was excellent for the FABER test.30 Cibulka28 found the FABER test was responsive in detecting improvement in ROM and in report of pain in patients with hip pain. The MDC95, determined from a sample of 22 patients with knee OA and 17 subjects without lower extremity symptoms or known pathology, was 8° for ROM and 1.6 points on the NPRS.30 The clinically important difference for the NPRS, derived from patients with low back pain, has been shown to be a reduction of 2 points.27,51

The Scour Test
ICF category	Measurement of impairment of body function: pain in joints
Description	A test to determine the irritability of the hip joint
Measurement method	The hip Scour test is performed with the patient lying in the supine position while the clinician flexes and adducts the hip until resistance to movement is detected. The clinician then maintains flexion into resistance and gently moves the hip into abduction, then bringing the hip through 2 full arcs of motion. If the patient reports no pain, then the examiner repeats the test while applying long-axis compression through the femur. This test must be administered with some caution so as to not irritate the hip joint. The patient is asked to rate the pain experienced during the movement on a 0-to-10 NPRS.30
Nature of variable	Ordinal
Units of measurement	0-to-10 NPRS
Measurement properties	The intratester reliability of the Scour test is good (ICC = 0.87; 95%CI: 0.76–0.93) for rating of hip pain.30 The MCID for the NPRS has been shown to be a reduction of 2 points.27,51 The MDC95 for the Scour test was determined from a sample of 22 patients with knee OA and 17 subjects without lower extremity symptoms or known pathology. The MDC95 for pain was a change of more than 1.6 points on the 0-to-10 NPRS.30

PROGNOSIS

 In most cases, OA of the hip progresses slowly197 with total hip replacement/arthroplasty (THR/THA) being the primary clinical endpoint for individuals with severe hip OA.69 The prognosis of hip OA depends primarily on the extent of radiographic evidence of hip OA.167The severity and progression of hip OA is commonly assessed with the Kellgren/Lawrence scale of joint space narrowing on plain film radiographs.99 A patient's baseline Kellgren/Lawrence radiographic grade is an important predictive factor for having THA.44, 160, 199 Reijman et al159 found that a Kellgren/Lawrence score of II or higher is a strong predictor of progression in patients with hip OA. Gossec et al70 reported that a Kellgren/Lawrence grade of III had an odds ratio of 3.3 and a grade of IV had an odds ratio of 5.3 that patients would have a THA. Gossec et al70 also reported that the most important predictive factors of having a THA include Kellgren/Lawrence radio-graphic grades of III or higher, a high global assessment of pain, and a previous trial of nonsteroidal anti-inflammatory drugs (NSAIDs).4, 70, 72 Altman et al5 have suggested that the measurement of individual radiographic features may be superior to the Kellgren/Lawrence global measurement in detecting arthritic progression. In OA of the hip, a single anteroposterior radiograph assessing for joint space narrowing and cyst formation yielded high sensitivity in detecting change. The MCID for joint space narrowing progression is greater than 0.5 mm/y.4, 43 The rate of joint space narrowing in patients with slowly developing hip OA is less than 0.2 mm/y and in patients with rapidly developing hip OA greater than 0.2 mm/y.66 In summary, joint space narrowing and the Kellgren/Lawrence scale are important prognostic predictors of OA while joint space narrowing may be the best indicator of structural OA progression in patients with hip OA.

 Other indicators for performing a THA include previous use of NSAIDs and pain of at least 47 mm on a 100-mm pain scale for over 6 months.70 Pain and function appear to be important criteria when considering THA.215

 THA is the most common surgical procedure for end-stage hip OA. Despite the success of THA of the hip and knee over the last 30-plus years, the criteria for when to perform such surgery are not clear.3There have been several attempts to develop guidelines to determine the appropriate time to perform joint replacement surgery, however few are supported by research.3 Currently, there is no consensus on the appropriate time to recommend surgery as a clinical end point.3 However, the Group for the Respect of Ethics and Excellence in Science (GREES) suggests that conservative intervention has failed if a patient does not experience a reduction in symptoms, such as a 20% to 25% improvement on the pain subscale of the WOMAC, and has a progressive loss of joint space of between 0.3 and 0.7 mm/year.3

Go to:

CLINICAL GUIDELINES

Interventions

A variety of interventions have been described for the treatment of hip OA and there is fair evidence from randomized clinical trials and systematic reviews to support the benefits of physical therapy intervention in these patients.

ANTI-INFLAMMATORY AGENTS

 Both over-the-counter and prescribed anti-inflammatory agents including NSAIDs, Cox-2 inhibitors, and steroid injections are recommended as part of a multidisciplinary treatment approach to hip OA.216 Randomized clinical trials evaluating the use of NSAIDs have shown NSAIDs can be effective for the temporary relief of symptoms and improvement in function in patients with hip OA.189 However, it should be noted that this class of drugs is not without risk for serious adverse events including increased gastrointestinal bleeding.67

 There is evidence to support the use of corticos-teroid injection in patients with hip OA to provide short-term pain relief.155, 163 A recent placebo-controlled trial confirmed corticosteroid injection can be an effective treatment of pain in hip OA, with benefits lasting up to 3 months.105

 Some evidence does suggest some NSAIDs may increase the progression of hip OA by decreasing gly-cosaminogly can synthesis22, 86, 147, 159 however, further studies are needed.

ALTERNATIVE/COMPLEMENTARY MEDICATION

 Glucosamine and other similar supplements are commonly suggested for individuals with hip OA. To date, randomized controlled trials evaluating the use of glucosamines have shown mixed results.130, 131, 205 Most of the positive results are for short-term improvement in pain and in function.132 A recent meta-analysis of chondroitin (a specific glucosamine commonly found in articular cartilage) for OA of the hip indicates the symptomatic benefit of chondroitin is minimal or nonexistent and the use of chondroitin in clinical practice should be discouraged.158Glucosamines (also called glycosamino-glycans) are an important component of normal connective tissue physiology; however, the short or long-term use of glucosamines is not recommended at this time in patients with hip OA.

 There is some evidence to support the short-term use of injectable viscosupplementation with hyaluronic acid into hip joint of patients with hip OA.34 Despite a paucity of evidence, the use of injectable synthetic hyaluronic acid (hyaluronan) into the hip joint has been shown to be an effective treatment for symptomatic hip OA.33, 194, 195 Evidence also shows that injectable hyaluronan works best in mild to moderate hip OA, especially when conservative therapy has failed.39 A recent published meta-analysis suggests the benefit of hyaluronan for the treatment of hip OA,34 but so far it is only approved by the Federal Drug Administration (FDA) for the knee. More controlled studies are needed to show its effectiveness in patients with hip OA.34

PATIENT EDUCATION

 Studies have shown the benefit of patient education in the self-management of patients with arthritis in decreasing pain, improving function, reducing stiffness and fatigue, and reducing medical usage.26, 58, 87, 88, 216 A meta-analysis has shown patient education can provide on average 20% more pain relief when compared to NSAIDs alone in patients with hip OA or rheumatoid arthritis.174

 An approach, called Hip School, that includes primarily patient education as an intervention has been shown to be effective in a preliminary study for patients with signs and symptoms of hip OA.104 The Hip School highlights the need for educating patients with hip OA, especially understanding the importance of preserving hip ROM and muscle function, understanding what therapy is effective and what is not, and when surgery is likely indicated.

 Clinicians should consider the use of patient education to teach activity modification, exercise, weight reduction when overweight, and methods of unloading the arthritic joints.

FUNCTIONAL, GAIT, AND BALANCE TRAINING

 Patients with hip OA often have gait abnormalities such as asymmetry in weight bearing and step length.29 Assistive device are often used in patients with hip OA to reduce the pain and activity limitations associated with this condition.196 A cane in the contralateral hand and choosing to carry loads in the ipsilateral hand has been shown to be effective in reducing hip abductor muscles activity133, 143 and acetabular contact pressures.133, 143 One study has shown a cane in the opposite hand can reduce hip load, reduce hip pain, and improve function in patients with hip OA.142

 Functional, gait, and balance training is recommended to address impairments of prop-rioception, balance, and strength, which are all commonly found in individuals with lower extremity arthritis. These deficits can contribute to higher fall risk scores in older individuals.173 Functional training of a small cohort of elderly individuals with lower extremity impairment demonstrated improved functional performance. Subjects underwent a program consisting of exercises simulating activities of daily living (such as gait, rising from a chair, reaching, stepping, and squatting down) performed at 3 different speeds (self selected, fast, and slow) with progressive levels of difficulty. When subjects completed 1 task level correctly and without fatigue the next level was introduced.134

 Functional, gait, and balance training, including the use of assistive devices such as canes, crutches, and walkers, can be used in patients with hip osteoarthritis to improve function associated with weight-bearing activities.

MANUAL THERAPY

 Some evidence exists for using manual therapy to increase hip joint ROM and reduce pain short-term in patients with hip OA, especially in patients who do not have signs of severe hip OA (eg, osteo-phytes and significant joint space narrowing).82

One study has recommended mobilization/manipulation as a component of the management program for patients with hip OA.82 This randomized controlled trial compared the use of manual therapy and therapeutic exercises in patients with hip OA.82 The manual therapy session consisted of (1) stretching techniques of shortened muscles surrounding the hip joint, (2) traction of the hip joint, (3) traction manipulation (high-velocity thrust technique) in each limited position. All manipulations were repeated during each session until the therapist concluded optimal results of the session were achieved. The focus of the therapeutic exercise intervention was to improve hip ROM, muscle length, and strength along with walking endurance. The outcomes for hip function (Harris Hip Score), ROM, and pain as measured by the visual analogue scale were compared for specific subgroups of hip OA depending on limited function, ROM, or level of pain.82 After 5 weeks of intervention, the success rate (primary outcome) of manual therapy was 81% versus 50% for exercise therapy (odds ratio, 1.92; 95% CI: 1.30–2.60).82 Manual therapy was found to be superior to exercise therapy in some patients with hip OA but was not shown to be any more effective than exercise in patients with highly limited function, ROM, or high levels of pain.82 When intervention stopped, the improvements in function declined after 5 weeks. However, some improvement lasted up to 29 weeks for the patients in the manual therapy group.82

 MacDonald et al123 published a case series describing the outcomes of individual patients with hip OA treated with manual physical therapy and exercise. The series included 7 patients diagnosed with hip OA on the basis of the clinical examination. All patients were treated with manual physical therapy followed by exercises to increase hip strength and ROM. Six of 7 patients completed a Harris Hip Score at initial examination and discharge from physical therapy. Patients exhibited reductions in pain and increases in passive ROM, as well as a clinically meaningful improvement in function.123

Harding et al,76 in a study using cadaveric models, showed that a posterior-anterior (P/A) mobilization of the hip produced about 1 mm of movement in the hip joint when using a force of 356 N. Distal distraction of the hip, however, created motion ranging from 2 to 7 mm of displacement when using forces between 89 to 356 N.76 This cadaveric study suggests that when attempting to mobilize the hip joint, the amount of movement produced at the hip most likely depends on the direction the joint is mobilized.76

Risks of adverse events associated with manual therapy of the hip typically include self-limiting soreness of the hip region. There are no studies documenting an increased risk for serious adverse events associated with manual therapy of the hip.

 Clinicians should consider the use of manual therapy procedures to provide short-term pain relief and improve hip mobility and function in patients with mild hip osteoarthritis.

FLEXIBILITY, STRENGTHENING, AND ENDURANCE EXERCISES

There are 3 categories of exercise therapy employed for OA: ROM/flexibility exercises, muscle-strengthening exercises, and aerobic conditioning/endurance exercises. Often all 3 types of exercises are utilized jointly for patients with hip OA. Adequate joint motion and elasticity of periarticu-lar tissues are necessary for cartilage nutrition and health, protection of joint structures from damaging impact loads, function, and comfort in daily activities. Exercise to regain or maintain motion and flexibility is achieved by routines of low-intensity, controlled movements that do not cause increased pain.52 Muscle weakness around an osteoarthritic joint is a common finding.171Progressive resistive/strengthening exercises load muscles in a graduated manner to allow for strengthening while limiting tissue injury. Aerobic exercise has been shown to be helpful in patients with hip OA.216Aerobic exercises are usually designed to provide a workload to the cardiovascular and pulmonary system at 60% to 80% of maximal capacity and sustained for duration of at least 20 minutes.216

 ROM and strengthening exercises have been advocated by many authors as a component of the management for patients with hip OA.32, 56, 80, 85, 123, 135,150,157,164,165,176,190,192,193,216 Van Baar et al191 showed that exercise is effective in patients with OA of the hip using an exercise program previously reported by Oostendorp et al146 that consisted of flexibility, hip muscle strengthening, and an aerobic exercise program. The emphasis of the stretching was on hip muscles, including the iliopsoas, rectus femoris, and hip adductors. Before stretching it was advised to heat the specific muscle and then stretch gently without excessive force for 15 to 30 seconds, performed 5 to 10 times preferably daily, but at least 3 times a week. Hip muscle strengthening was performed with either free weights or exercise machines.146, 191 Depending on the therapist's findings on evaluation and the patient's needs and goals, the specific type, intensity, frequency, and duration of exercise were determined. The typical exercise prescription ranged from 1 to 3 times per week with a duration of 30 minutes for each exercise session for 12 weeks.191 Treatment could be discontinued within the 12-week period if, according to the therapist, the treatment goals were achieved. When patients stopped exercising after 12 weeks, Van Baar et al191 reported that the beneficial effects of reduced pain, less use of medication, and improved function declined, losing any earlier gain that were made.192 A confounding factor of the Van Baar et al192 trial was that data from patients with hip OA were pooled with data from patients with knee OA. Therefore, determining specific treatment effect in patients with hip OA was not possible.

 Many of the published articles on exercise report findings that combine subjects with either hip or knee OA. However, in a recent meta-analysis, Hernandez-Molina et al79 contacted authors of several studies and obtained data which only pertained to hip OA. They found 9 articles where hip-strengthening exercises showed a beneficial effect in reducing pain and improving function in patients with hip OA.79 In another study, moderate evidence was found for long-term effectiveness on reduced pain, improved self-reported physical function, and improved observed physical function with exercise for patients with hip OA.150Studies have also shown aerobic exercise may offer additional improvement in function when combined with stretching and strengthening.153, 216

 Minor et al136 studied 120 patients with well-defined rheumatoid arthritis (n = 40) or OA (n = 80) of the hip, knee, or ankle. Patients received 1 of 3 interventions: a stretching and strengthening exercise program (control), or the same program combined with 1 of 2 aerobic conditioning/endurance exercises: pool activities or walking. All patients participated in a 12-week program, which met 3 times each week for 1 hour, and all performed supervised ROM and isometric exercises. The 2 groups doing the aerobic exercises also performed up to 30 minutes of walking or pool exercises to increase their heart rates to 60% to 80% of each person's estimated baseline maximum. At 12 weeks, study participants were assessed for changes in aerobic capacity, flexibility (trunk bending, shoulder ROM, and ankle ROM), function tests (exercise endurance on a treadmill test, time to walk 50 feet, and reported daily activity), and self-reported health status using the Arthritis Impact Measurement Scale, which is an arthritis-specific functional status instrument that reliably measures psychological health, physical health, and pain. Patients in both of the aerobic exercise groups increased aerobic capacity and decreased times to walk 50 feet compared to their baseline scores and compared to the patients in the control group. Following 12 weeks of supervised exercises, all groups demonstrated improved trunk, shoulder, and ankle joint flexibility. The gains in endurance and flexibility in all 3 groups were achieved without exacerbating the study participant's arthritis signs and symptoms.

 The use of aquatic exercise (hydrotherapy) in the treatment of patients with OA of the hip has been assessed.13, 32, 55, 57, 71, 80 Aquatic exercise appears to have some beneficial short-term effects for patients with hip and/or knee OA while no long-term effects have been documented.13 In a recent study Hinman et al80 used a randomized controlled trial and compared a 6-week program of aquatic physical therapy to no intervention. The aquatic physical therapy group demonstrated significantly less pain and improved physical function, strength, and quality of life after the intervention.80 However, effect size calculations revealed only small benefits of aquatic physical therapy for pain, stiffness, right hip abductors strength, and quality of life, and doubtful clinical benefits for physical function and left hip abductors strength.80 Patients who have an intolerance to land-based exercise because of pain or obesity may better tolerate aquatic based exercise.80

 Clinicians should consider the use of flexibility, strengthening, and endurance exercises in patients with hip osteoarthritis.

Go to:

CLINICAL GUIDELINES

Summary of Recommendations

 PATHOANATOMICAL FEATURES

Clinicians should assess for impairments in mobility of the hip joint and strength of the surrounding muscles, especially the hip abductor muscles, when a patient presents with hip pain.

 RISK FACTORS

Clinicians should consider age, hip developmental disorders, and previous hip joint injury as risk factors for hip osteoarthritis.

 DIAGNOSIS/CLASSIFICATION

Moderate lateral or anterior hip pain during weight bearing, in adults over the age of 50 years, with morning stiffness less than 1 hour, with limited hip internal rotation and hip flexion by more than 15° when comparing the painful to the nonpainful side are useful clinical findings to classify a patient with hip pain into the International Statistical Classification of Diseases and Related Health Problems (ICD) category of unilateral coxarthrosis and the associated International Classification of Functioning, Disability, and Health (ICF) impairment-based category of hip pain (b2816 Pain in joints) and mobility deficits (b7100 Mobility of a single joint).

 DIFFERENTIAL DIAGNOSIS

Clinicians should consider diagnostic classifications other than osteoarthritis of the hip when the patient's history, reported activity limitations, or impairments of body function and structure are not consistent with those presented in the diagnosis/classification section of this guideline - or - when the patient's symptoms are not diminishing with interventions aimed at normalization of the patient's impairments of body function.

 EXAMINATION - OUTCOME MEASURES

Clinicians should use validated functional outcome measures, such as the Western Ontario and McMaster Universities Osteoarthritis Index, the Lower Extremity Functional Scale, and the Harris Hip Score before and after interventions intended to alleviate the impairments of body function and structure, activity limitations, and participation restrictions associated with hip osteoarthritis.

 EXAMINATION - ACTIVITY LIMITATION AND PARTICIPATION RESTRICTION MEASURES

Clinicians should utilize easily reproducible physical performance measures, such as the 6-minute walk, self-paced walk, stair measure, and timed up-and-go tests to assess activity limitation and participation restrictions associated with their patient's hip pain and to assess the changes in the patient's level of function over the episode of care.

 INTERVENTIONS - PATIENT EDUCATION

Clinicians should consider the use of patient education to teach activity modification, exercise, weight reduction when overweight, and methods of unloading the arthritic joints.

 INTERVENTIONS - FUNCTIONAL, GAIT, AND BALANCE TRAINING

Functional, gait, and balance training, including the use of assis-tive devices such as canes, crutches, and walkers, can be used in patients with hip osteoarthritis to improve function associated with weight-bearing activities.

 INTERVENTIONS - MANUAL THERAPY

Clinicians should consider the use of manual therapy procedures to provide short-term pain relief and improve hip mobility and function in patients with mild hip osteoarthritis.

 INTERVENTIONS - FLEXIBILITY, STRENGTHENING, AND ENDURANCE EXERCISES

Clinicians should consider the use of flexibility, strengthening, and endurance exercises in patients with hip osteoarthritis

Go to:

Contributor Information

Michael T. Cibulka, Assistant Professor Physical Therapy Program Maryville University St Louis, MO 63141 ; Email: ude.ellivyram@aklubicm.

Douglas M. White, Principal & Consultant Milton Orthopaedic & Sports Physical Therapy, PC 101 Blue Hills Parkway Milton, MA 02186 ; Email: moc.ohtronotlim@etihw.rd.

Judith Woehrle, Director, Physical Therapy Program Maryville University 650 Maryville University Dr St Louis, MO 63141 ; Email: ude.ellivyram@elrheowj.

Marcie Harris-Hayes, Assistant Professor of Physical Therapy and Orthopaedic Surgery Washington University School of Medicine St Louis, MO 63108 ; Email: ude.ltsuw@amsirrah.

Keelan Enseki, Centers for Rehab Services University of Pittsburgh Medical Center Center for Sports Medicine 3200 South Water Street Pittsburgh, PA 15203 ; Email: ude.cmpu@rkikesne.

Timothy L. Fagerson, Director, Spine Orthopaedic Sport Physical Therapy 148 Linden St, Suite B-8 Wellesley, MA 02482 ; Email: ten.nozirev@nosregaf.

James Slover, Assistant Professor NYU Hospital for Joint Diseases 301 East 17th St Suite 1616 New York, NY 10003 ; Email: gro.cmuyn@revols.semaj.

Joseph J. Godges, ICF Practice Guidelines Coordinator Orthopaedic Section APTA, Inc La Crosse, Wisconsin ; Email: gro.tpohtro@fci.

Go to:

REFERENCES

1. Abraham E, Gonzalez MH, Pratap S, Amirouche F, Atluri P, Simon P. Clinical implications of anatomical wear characteristics in slipped capital femoral epiphysis and primary osteoarthritis. J Pediatr Orthop.2007;27:788–795. http://dx.doi.org/10.1097/BPO.0b013e3181558c94. [PubMed]

2. Altman R, Alarcon G, Appelrouth D, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum. 1991;34:505–514. [PubMed]

3. Altman RD, Abadie E, Avouac B, et al. Total joint replacement of hip or knee as an outcome measure for structure modifying trials in osteoarthritis. Osteoarthritis Cartilage. 2005;13:13–19.http://dx.doi.org/10.1016/j.joca.2004.10.012. [PubMed]

4. Altman RD, Bloch DA, Dougados M, et al. Measurement of structural progression in osteoarthritis of the hip: the Barcelona consensus group. Osteoarthritis Cartilage. 2004;12:515–524. [PubMed]

5. Altman RD, Fries JF, Bloch DA, et al. Radiographic assessment of progression in osteoarthritis. Arthritis Rheum. 1987;30:1214–1225. [PubMed]

6. Altman RD, Hochberg M, Murphy WA, Jr, Wolfe F, Lequesne M. Atlas of individual radiographic features in osteoarthritis. Osteoarthritis Cartilage. 1995;3(Suppl A):3–70. [PubMed]

7. American Academy of Orthopedic Surgeons. [Accessed January 20, 2008];Osteoarthritis of the Hip: A Compendium of Evidence-based Information and Resources. 2003 Available at:http://www.aaos.org/research/documents/oainfo_hip.asp.

8. Andrianakos AA, Kontelis LK, Karamitsos DG, et al. Prevalence of symptomatic knee, hand, and hip osteoarthritis in Greece. The ESORDIG study. J Rheumatol. 2006;33:2507–2513. [PubMed]

9. Angst F, Aeschlimann A, Michel BA, Stucki G. Minimal clinically important rehabilitation effects in patients with osteoarthritis of the lower extremities. J Rheumatol. 2002;29:131–138. [PubMed]

10. Angst F, Aeschlimann A, Stucki G. Smallest detectable and minimal clinically important differences of rehabilitation intervention with their implications for required sample sizes using WOMAC and SF-36 quality of life measurement instruments in patients with osteoarthritis of the lower extremities. Arthritis Rheum.2001;45:384–391. http://dx.doi.org/10.1002/1529-0131(200108)45:4<384::AID-ART352>3.0.CO;2-0.[PubMed]

11. Arokoski MH, Arokoski JP, Haara M, et al. Hip muscle strength and muscle cross sectional area in men with and without hip osteoarthritis. J Rheumatol. 2002;29:2185–2195. [PubMed]

12. Atamaz F, Hepguler S, Oncu J. Translation and validation of the Turkish version of the arthritis impact measurement scales 2 in patients with knee osteoarthritis. J Rheumatol. 2005;32:1331–1336. [PubMed]

13. Bartels EM, Lund H, Hagen KB, Dagfinrud H, Christensen R, Danneskiold-Samsoe B. Aquatic exercise for the treatment of knee and hip osteoarthritis. Cochrane Database Syst Rev. 2007:CD005523.http://dx.doi.org/10.1002/14651858.CD005523.pub2. [PubMed]

14. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15:1833–1840. [PubMed]

15. Bierma-Zeinstra SM, Koes BW. Risk factors and prognostic factors of hip and knee osteoarthritis. Nat Clin Pract Rheumatol. 2007;3:78–85. http://dx.doi.org/10.1038/ncprheum0423. [PubMed]

16. Bierma-Zeinstra SM, Oster JD, Bernsen RM, Verhaar JA, Ginai AZ, Bohnen AM. Joint space narrowing and relationship with symptoms and signs in adults consulting for hip pain in primary care. J Rheumatol. 2002;29:1713–1718. [PubMed]

17. Binkley JM, Stratford PW, Lott SA, Riddle DL. The Lower Extremity Functional Scale (LEFS): scale development, measurement properties, and clinical application. North American Orthopaedic Rehabilitation Research Network. Phys Ther. 1999;79:371–383. [PubMed]

18. Birrell F, Croft P, Cooper C, Hosie G, Macfarlane G, Silman A. Predicting radiographic hip osteoarthritis from range of movement. Rheumatology (Oxford) 2001;40:506–512. [PubMed]

19. Birrell F, Croft P, Cooper C, Hosie G, Macfarlane GJ, Silman A. Radiographic change is common in new presenters in primary care with hip pain. PCR Hip Study Group. Rheumatology (Oxford) 2000;39:772–775. [PubMed]

20. Birrell F, Silman A, Croft P, Cooper C, Hosie G, Macfarlane G. Syndrome of symptomatic adult acetabular dysplasia (SAAD syndrome) Ann Rheum Dis. 2003;62:356–358. [PMC free article] [PubMed]

21. Boutry N, Paul C, Leroy X, Fredoux D, Migaud H, Cotten A. Rapidly destructive osteoarthritis of the hip: MR imaging findings. AJR Am J Roentgenol. 2002;179:657–663. [PubMed]

22. Brandt KD. Effects of nonsteroidal anti-inflammatory drugs on chondrocyte metabolism in vitro and in vivo. Am J Med. 1987;83:29–34. [PubMed]

23. Buckland-Wright JC. Quantitative radiography of osteoarthritis. Ann Rheum Dis. 1994;53:268–275.[PMC free article] [PubMed]

24. Buckwalter JA, Lane NE. Athletics and osteoarthritis. Am J Sports Med. 1997;25:873–881. [PubMed]

25. Buckwalter JA, Martin JA. Sports and osteoarthritis. Curr Opin Rheumatol. 2004;16:634–639. [PubMed]

26. Callahan LF, Mielenz T, Freburger J, et al. A randomized controlled trial of the people with arthritis can exercise program: symptoms, function, physical activity, and psychosocial outcomes. Arthritis Rheum.2008;59:92–101. http://dx.doi.org/10.1002/art.23239. [PubMed]

27. Childs JD, Piva SR, Fritz JM. Responsiveness of the numeric pain rating scale in patients with low back pain. Spine. 2005;30:1331–1334. [PubMed]

28. Cibulka MT. Determination and significance of femoral neck anteversion. Phys Ther. 2004;84:550–558.[PubMed]

29. Cichy B, Wilk M. Gait analysis in osteoarthritis of the hip. Med Sci Monit. 2006;12:CR507–CR513.[PubMed]

30. Cliborne AV, Wainner RS, Rhon Dl, et al. Clinical hip tests and a functional squat test in patients with knee osteoarthritis: reliability, prevalence of positive test findings, and short-term response to hip mobilization. J Orthop Sports Phys Ther. 2004;34:676–685. http://dx.doi.org/10.2519/jospt.2004.1432.[PubMed]

31. Click Fenter P, Bellew JW, Pitts TA, Kay RE. Reliability of stabilised commercial dynamometers for measuring hip abduction strength: a pilot study. Br J Sports Med. 2003;37:331–334. [PMC free article][PubMed]

32. Cochrane T, Davey RC, Matthes Edwards SM. Randomised controlled trial of the cost-effectiveness of water-based therapy for lower limb osteoarthritis. Health Technol Assess. 2005;9:1–114. iii-iv, ix-xi.[PubMed]

33. Conrozier T, Bertin P, Bailleul F, et al. Clinical response to intra-articular injections of hylan G-F 20 in symptomatic hip osteoarthritis: the OMER-ACT-OARSI criteria applied to the results of a pilot study. Joint Bone Spine. 2006;73:705–709. http://dx.doi.Org/10.1016/j.jbspin.2006.02.008. [PubMed]

34. Conrozier T, Vignon E. Is there evidence to support the inclusion of viscosupplementation in the treatment paradigm for patients with hip osteoarthritis? Clin Exp Rheumatol. 2005;23:711–716. [PubMed]

35. Cooper C, Inskip H, Croft P, et al. Individual risk factors for hip osteoarthritis: obesity, hip injury, and physical activity. Am J Epidemiol. 1998;147:516–522. [PubMed]

36. Croft P, Coggon D, Cruddas M, Cooper C. Osteoarthritis of the hip: an occupational disease in farmers.BMJ. 1992;304:1269–1272. [PMC free article] [PubMed]

37. Croft P, Cooper C, Wickham C, Coggon D. Defining osteoarthritis of the hip for epidemiologic studies.Am J Epidemiol. 1990;132:514–522. [PubMed]

38. Croft PR, Nahit ES, Macfarlane GJ, Silman AJ. Interobserver reliability in measuring flexion, internal rotation, and external rotation of the hip using a plurimeter. Ann Rheum Dis. 1996;55:320–323.[PMC free article] [PubMed]

39. Dagenais S. Intra-articular hyaluronic acid (viscosupplementation) for hip osteoarthritis. Issues Emerg Health Technol. 2007:1–4. [PubMed]

40. Dagenais S, Garbedian S, Wai EK. Systematic review of the prevalence of radiographic primary hip osteoarthritis. Clin Orthop Relat Res. 2009;467:623–637. http://dx.doi.org/10.1007/sll999-008-0625-5.[PMC free article] [PubMed]

41. D'Ambrosia RD. Epidemiology of osteoarthritis. Orthopedics. 2005;28:s201–S205. [PubMed]

42. Dougados M, Gueguen A, Nguyen M, et al. Radiographic features predictive of radiographic progression of hip osteoarthritis. Rev Rhum Engl Ed. 1997;64:795–803. [PubMed]

43. Dougados M, Gueguen A, Nguyen M, et al. Radiological progression of hip osteoarthritis: definition, risk factors and correlations with clinical status. Ann Rheum Dis. 1996;55:356–362. [PMC free article][PubMed]

44. Dougados M, Gueguen A, Nguyen M, et al. Requirement for total hip arthroplasty: an outcome measure of hip osteoarthritis? J Rheumatol. 1999;26:855–861. [PubMed]

45. Dougados M, Villers C, Amor B. Sensitivity to change of various roentgenological severity scoring systems for osteoarthritis of the hip. Rev Rhum Engl Ed. 1995;62:169–173. [PubMed]

46. Eh rich EW, Davies GM, Watson DJ, Bolognese JA, Seidenberg BC, Bellamy N. Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities osteoarthritis index questionnaire and global assessments in patients with osteoarthritis. J Rheumatol. 2000;27:2635–2641. [PubMed]

47. Ellison JB, Rose SJ, Sahrmann SA. Patterns of hip rotation range of motion: a comparison between healthy subjects and patients with low back pain. Phys Ther. 1990;70:537–541. [PubMed]

48. Enright PL. The six-minute walk test. Respir Care. 2003;48:783–785. [PubMed]

49. Ezoe M, Naito M, Inoue T. The prevalence of acetabular retroversion among various disorders of the hip.J Bone Joint Surg Am. 2006;88:372–379. http://dx.doi.org/10.2106/JBJS.D.02385. [PubMed]

50. Fagerson T. The Hip Handbook. Philadelphia, PA: W.B. Saunders Co; 1987.

51. Farrar JT, Young JR, Jr, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001;94:149–158. [PubMed]

52. Felson DT, Lawrence RC, Dieppe PA, et al. Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med. 2000;133:635–646. [PubMed]

53. Fife RS. Imaging, arthroscopy, and markers in osteoarthritis. Curr Opin Rheumatol. 1992;4:560–565.[PubMed]

54. Fitzgerald RH., Jr Acetabular labrum tears. Diagnosis and treatment. Clin Orthop Relat Res. 1995:60–68.[PubMed]

55. Foley A, Halbert J, Hewitt T, Crotty M. Does hydrotherapy improve strength and physical function in patients with osteoarthritis-a randomised controlled trial comparing a gym based and a hydrotherapy based strengthening programme. Ann Rheum Dis. 2003;62:1162–1167. [PMC free article] [PubMed]

56. Fransen M, McConnell S, Bell M. Exercise for osteoarthritis of the hip or knee. Cochrane Database Syst Rev. 2003:CD004286. http://dx.doi.org/10.1002/14651858.CD004286. [PubMed]

57. Fransen M, Nairn L, Winstanley J, Lam P, Edmonds J. Physical activity for osteoarthritis management: a randomized controlled clinical trial evaluating hydrotherapy or Tai Chi classes. Arthritis Rheum.2007;57:407–414. http://dx.doi.org/10.1002/art.22621. [PubMed]

58. Fries JF, Carey C, McShane DJ. Patient education in arthritis: randomized controlled trial of a mail-delivered program. J Rheumatol. 1997;24:1378–1383. [PubMed]

59. Gelber AC, Hochberg MC, Mead LA, Wang NY, Wigley FM, Klag MJ. Body mass index in young men and the risk of subsequent knee and hip osteoarthritis. Am J Med. 1999;107:542–548. [PubMed]

60. Gelber AC, Hochberg MC, Mead LA, Wang NY, Wigley FM, Klag MJ. Joint injury in young adults and risk for subsequent knee and hip osteoarthritis. Ann Intern Med. 2000;133:321–328. [PubMed]

61. Gelberman RH, Cohen MS, Shaw BA, Kasser JR, Griffin PP, Wilkinson RH. The association of femoral retroversion with slipped capital femoral epiphysis. J Bone Joint Surg Am. 1986;68:1000–1007.[PubMed]

62. Gershuni DH. Preliminary evaluation and prognosis in Legg-Calve-Perthes disease. Clin Orthop Relat Res. 1980:16–22. [PubMed]

63. Gofton JP. Studies in osteoarthritis of the hip. IV. Biomechanics and clinical considerations. Can Med Assoc J. 1971;104:1007–1011. [PMC free article] [PubMed]

64. Gofton JP, Trueman GE. Studies in osteoarthritis of the hip. II. Osteoarthritis of the hip and leg-length disparity. Can Med Assoc J. 1971;104:791–799. [PMC free article] [PubMed]

65. Gofton JP, Trueman GE. Unilateral idiopathic osteoarthritis of the hip. Can Med Assoc J. 1967;97:1129–1132. [PMC free article] [PubMed]

66. Goker B, Doughan AM, Schnitzer TJ, Block JA. Quantification of progressive joint space narrowing in osteoarthritis of the hip: longitudinal analysis of the contralateral hip after total hip arthroplasty. Arthritis Rheum. 2000;43:988–994. http://dx.doi.org/10.1002/1529-0131(200005)43:5<988::AID-ANR5>3.0.CO;2-X. [PubMed]

67. Goldkind L, Simon LS. Patients, their doctors, nonsteroidal anti-inflammatory drugs and the perception of risk. Arthritis Res Ther. 2006;8:105. http://dx.doi.org/10.1186/arl924. [PMC free article] [PubMed]

68. Golightly YM, Allen KD, Renner JB, Helmick CG, Salazar A, Jordan JM. Relationship of limb length inequality with radiographic knee and hip osteoarthritis. Osteoarthritis Cartilage. 2007;15:824–829.http://dx.doi.org/10.1016/j.joca.2007.01.009. [PMC free article] [PubMed]

69. Gossec L, Hawker G, Davis AM, et al. OMERACT/OARSI initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis. J Rheumatol. 2007;34:1432–1435. [PubMed]

70. Gossec L, Tubach F, Baron G, Ravaud P, Logeart I, Dougados M. Predictive factors of total hip replacement due to primary osteoarthritis: a prospective 2 year study of 505 patients. Ann Rheum Dis.2005;64:1028–1032. http://dx.doi.org/10.1136/ard.2004.029546. [PMC free article] [PubMed]

71. Green J, McKenna F, Redfern EJ, Chamberlain MA. Home exercises are as effective as outpatient hydrotherapy for osteoarthritis of the hip. BrJ Rheumatol. 1993;32:812–815. [PubMed]

72. Gregory JS, Waarsing JH, Day J, et al. Early identification of radiographic osteoarthritis of the hip using an active shape model to quantify changes in bone morphometric features: can hip shape tell us anything about the progression of osteoarthritis? Arthritis Rheum. 2007;56:3634–3643.http://dx.doi.org/10.1002/art.22982. [PubMed]

73. Grotle M, Hagen KB, Natvig B, Dahl FA, Kvien TK. Obesity and osteoarthritis in knee, hip and/or hand: an epidemiological study in the general population with 10 years follow-up. BMC Musculoskelet Disord. 2008;9:132. http://dx.doi.org/10.1186/1471-2474-9-132. [PMC free article] [PubMed]

74. Gunther KP, Puhl W, Brenner H, Sturmer T. Clinical epidemiology of hip and knee joint arthroses: an overview of the results of the “Ulm Osteoarthrosis Study” Z Rheumatol. 2002;61:244–249. [PubMed]

75. Guyatt GH, Sackett DL, Sinclair JC, Hayward R, Cook DJ, Cook RJ. Users’ guides to the medical literature. IX. A method for grading health care recommendations. Evidence-Based Medicine Working Group. JAMA. 1995;274:1800–1804. [PubMed]

76. Harding L, Barbe M, Shepard K, et al. Posterior-anterior glide of the femoral head in the acetabulum: a cadaver study. J Orthop Sports Phys Ther. 2003;33:118–125. [PubMed]

77. Harris WH. Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation. J Bone Joint Surg. Am.1969;51:737–755. [PubMed]

78. Harris-Hayes M, Wendl PM, Sahrmann SA, Van Dillen LR. Does stabilization of the tibiofemoral joint affect passive prone hip rotation range of motion measures in unimpaired individuals? A preliminary report.Physiother Theory Pract. 2007;23:315–323. http://dx.doi.org/10.1080/09593980701378108. [PubMed]

79. Hernandez-Molina G, Reichenbach S, Zhang B, Lavalley M, Felson DT. Effect of therapeutic exercise for hip osteoarthritis pain: results of a meta-analysis. Arthritis Rheum. 2008;59:1221–1228.http://dx.doi.org/10.1002/fcrt.24010. [PMC free article] [PubMed]

80. Hinman RS, Heywood SE, Day AR. Aquatic physical therapy for hip and knee osteoarthritis: results of a single-blind randomized controlled trial. Phys Ther. 2007;87:32–43. http://dx.doi.org/10.2522/ptj.20060006.[PubMed]

81. Hoaglund FT, Steinbach LS. Primary osteoarthritis of the hip: etiology and epidemiology. J Am Acad Orthop Surg. 2001;9:320–327. [PubMed]

82. Hoeksma HL, Dekker J, Ronday HK, et al. Comparison of manual therapy and exercise therapy in osteoarthritis of the hip: a randomized clinical trial. Arthritis Rheum. 2004;51:722–729.http://dx.doi.org/10.1002/art.20685. [PubMed]

83. Holm I, Bolstad B, Lutken T, Ervik A, Rokkum M, Steen H. Reliability of goniometric measurements and visual estimates of hip ROM in patients with osteoarthrosis. Physiother Res Int. 2000;5:241–248.[PubMed]

84. Holmberg S, Stiernstrom EL, Thelin A, Svardsudd K. Musculoskeletal symptoms among farmers and non-farmers: a population-based study. Int J Occup Environ Health. 2002;8:339–345. [PubMed]

85. Hopman-Rock M, Westhoff MH. The effects of a health educational and exercise program for older adults with osteoarthritis for the hip or knee. J Rheumatol. 2000;27:1947–1954. [PubMed]

86. Hugenberg ST, Brandt KD, Cole CA. Effect of sodium salicylate, aspirin, and ibuprofen on enzymes required by the chondrocyte for synthesis of chondroitin sulfate. J Rheumatol. 1993;20:2128–2133.[PubMed]

87. Hughes SL, Seymour RB, Campbell R, Pollak N, Huber G, Sharma L. Impact of the fit and strong intervention on older adults with osteoarthritis. Gerontologist. 2004;44:217–228. [PubMed]

88. Hughes SL, Seymour RB, Campbell RT, et al. Long-term impact of Fit and Strong! on older adults with osteoarthritis. Gerontologist. 2006;46:801–814. [PubMed]

89. Ingvarsson T, Hagglund G, Lohmander LS. Prevalence of hip osteoarthritis in Iceland. Ann Rheum Dis.1999;58:201–207. [PMC free article] [PubMed]

90. Inoue K, Wicart P, Kawasaki T, et al. Prevalence of hip osteoarthritis and acetabular dysplasia in french and Japanese adults. Rheumatology (Oxford) 2000;39:745–748. [PubMed]

91. Ippolito E, Tudisco C, Farsetti P. Long-term prognosis of Legg-Calve-Perthes disease developing during adolescence. J Pediatr Orthop. 1985;5:652–656. [PubMed]

92. Jacobsen S. Adult hip dysplasia and osteoarthritis. Studies in radiology and clinical epidemiology. Ada Orthop Suppl. 2006;77:1–37. [PubMed]

93. Jacobsen S, Romer L, Soballe K. Degeneration in dysplastic hips. A computer tomography study.Skeletal Radiol. 2005;34:778–784. http://dx.doi.org/10.1007/s00256-005-0019-7. [PubMed]

94. Jacobsen S, Sonne-Holm S. Hip dysplasia: a significant risk factor for the development of hip osteoarthritis. A cross-sectional survey. Rheumatology (Oxford) 2005;44:211–218.http://dx.doi.org/10.1093/rheumtology/keh436. [PubMed]

95. Jacobsen S, Sonne-Holm S, Soballe K, Gebuhr P, Lund B. Factors influencing hip joint space in asymptomatic subjects. A survey of 4151 subjects of the Copenhagen City Heart Study: the Osteoarthritis Substudy. Osteoarthritis Cartilage. 2004;12:698–703. http://dx.doi.0rg/10.1016/j.joca.2004.06.002.[PubMed]

96. Jarvholm B, Lundstrom R, Malchau H, Rehn B, Vingard E. Osteoarthritis in the hip and whole-body vibration in heavy vehicles. Int Arch Occup Environ Health. 2004;77:424–426.http://dx.doi.org/10.1007/S00420-004-0528-z. [PubMed]

97. Jordan JM, Linder GF, Renner JB, Fryer JG. The impact of arthritis in rural populations. Arthritis Care Res. 1995;8:242–250. [PubMed]

98. Karachalios T, Karantanas AH, Malizos K. Hip osteoarthritis: what the radiologist wants to know. Eur J Radiol. 2007;63:36–48. http://dx.doi.org/10.1016/j.ejrad.2007.03.022. [PubMed]

99. Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957;16:494–502. [PMC free article] [PubMed]

100. Kellgren JH, Lawrence JS, Bier F. Genetic Factors in Generalized Osteo-Arthrosis. Ann Rheum Dis.1963;22:237–255. [PMC free article] [PubMed]

101. Kendall FP, McCreary EK, Provance PG, Rodgers MM, Romani WA. Muscles: Testing and Function with Posture and Pain. 5th ed. Baltimore, MD: Lippincott, Williams, & Wilkins; 2005.

102. Kennedy DM, Stratford PW, Wessel J, Gollish JD, Penney D. Assessing stability and change of four performance measures: a longitudinal study evaluating outcome following total hip and knee arthroplasty.BMC Musculoskelet Disord. 2005;6:3. http://dx.doi.org/10.1186/1471-2474-6-3. [PMC free article][PubMed]

103. Kim YJ, Jaramillo D, Millis MB, Gray ML, Burstein D. Assessment of early osteoarthritis in hip dysplasia with delayed gadolinium-enhanced magnetic resonance imaging of cartilage. J Bone Joint Surg Am. 2003;85A:1987–1992. [PubMed]

104. Klassbo M, Larsson G, Harms-Ringdahl K. Promising outcome of a hip school for patients with hip dysfunction. Arthritis Rheum. 2003;49:321–327. http://dx.doi.org/10.1002Art.11110. [PubMed]

105. Lambert RG, Hutchings EJ, Grace MG, Jhangri GS, Conner-Spady B, Maksymowych WP. Steroid injection for osteoarthritis of the hip: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum.2007;56:2278–2287. http://dx.doi.org/10.1002/art.22739. [PubMed]

106. Lane NE, Lian K, Nevitt MC, et al. Frizzled-related protein variants are risk factors for hip osteoarthritis. Arthritis Rheum. 2006;54:1246–1254. http://dx.doi.org/10.1002/art.21673. [PubMed]

107. Lane NE, Michel B, Bjorkengren A, et al. The risk of osteoarthritis with running and aging: a 5-year longitudinal study. J Rheumatol. 1993;20:461–468. [PubMed]

108. Lane NE, Nevitt MC, Cooper C, Pressman A, Gore R, Hochberg M. Acetabular dysplasia and osteoarthritis of the hip in elderly white women. Ann Rheum Dis. 1997;56:627–630. [PMC free article][PubMed]

109. Lanyon P, Muir K, Doherty S, Doherty M. Assessment of a genetic contribution to osteoarthritis of the hip: sibling study. BMJ. 2000;321:1179–1183. [PMC free article] [PubMed]

110. Laslett M, Aprill CN, McDonald B. Provocation sacroiliac joint tests have validity in the diagnosis of sacroiliac joint pain. Arch Phys Med Rehabil. 2006;87:874–875. author reply 874–875http://dx.doi.Org/10.1016/j.apmr.2006.04.007. [PubMed]

111. Ledingham J, Dawson S, Preston B, Milligan G, Doherty M. Radiographic progression of hospital referred osteoarthritis of the hip. Ann Rheum Dis. 1993;52:263–267. [PMC free article] [PubMed]

112. Leibold MR, Huijbregts PA, Jensen R. Concurrent criterion-related validity of physical examination tests for hip labral lesions: a systematic review. J Man Manip Ther. 2008;16:E24–E41. [PMC free article][PubMed]

113. Lian K, Zmuda JM, Nevitt MC, et al. Type I collagen alpha1 Sp1 transcription factor binding site polymorphism is associated with reduced risk of hip osteoarthritis defined by severe joint space narrowing in elderly women. Arthritis Rheum. 2005;52:1431–1436. http://dx.doi.org/10.1002/art.21011. [PubMed]

114. Lievense A, Bierma-Zeinstra S, Verhagen A, Verhaar J, Koes B. Influence of work on the development of osteoarthritis of the hip: a systematic review. J Rheumatol. 2001;28:2520–2528. [PubMed]

115. Lievense AM, Bierma-Zeinstra SM, Verhagen AP, Bernsen RM, Verhaar JA, Koes BW. Influence of sporting activities on the development of osteoarthritis of the hip: a systematic review. Arthritis Rheum.2003;49:228–236. http://dx.doi.org/10.1002/art.11012. [PubMed]

116. Lievense AM, Bierma-Zeinstra SM, Verhagen AP, van Baar ME, Verhaar JA, Koes BW. Influence of obesity on the development of osteoarthritis of the hip: a systematic review. Rheumatology (Oxford)2002;41:1155–1162. [PubMed]

117. Lievense AM, Bierma-Zeinstra SM, Verhagen AP, Verhaar JA, Koes BW. Prognostic factors of progress of hip osteoarthritis: a systematic review. Arthritis Rheum. 2002;47:556–562.http://dx.doi.org/10.1002/art.10660. [PubMed]

118. Lievense AM, Koes BW, Verhaar JA, Bohnen AM, Bierma-Zeinstra SM. Prognosis of hip pain in general practice: a prospective followup study. Arthritis Rheum. 2007;57:1368–1374.http://dx.doi.org/10.1002/art.23094. [PubMed]

119. Lincoln TL, Suen PW. Common rotational variations in children. J Am Acad Orthop Surg.2003;11:312–320. [PubMed]

120. Lloyd-Roberts GC. The role of capsular changes in osteoarthritis of the hip joint. J Bone Joint Surg. Br.1953;35-B:627–642. [PubMed]

121. Loughlin J. The genetic epidemiology of human primary osteoarthritis: current status. Expert Rev Mol Med. 2005;7:l–12. http://dx.doi.org/10.1017/S1462399405009257. [PubMed]

122. Loughlin J, Dowling B, Chapman K, et al. Functional variants within the secreted frizzled-related protein 3 gene are associated with hip osteoarthritis in females. Proc Natl Acad Sci U S A. 2004;101:9757–9762. http://dx.doi.org/10.1073/pnas.0403456101. [PMC free article] [PubMed]

123. MacDonald CW, Whitman JM, Cleland JA, Smith M, Hoeksma HL. Clinical outcomes following manual physical therapy and exercise for hip osteoarthritis: a case series. J Orthop Sports Phys Ther.2006;36:588–599. http://dx.doi.org/10.2519/jospt.2006.2233. [PubMed]

124. MacGregor AJ, Antoniades L, Matson M, Andrew T, Spector TD. The genetic contribution to radiographic hip osteoarthritis in women: results of a classic twin study. Arthritis Rheum. 2000;43:2410–2416. http://dx.doi.org/10.1002/1529-0131(200011)43:11<2410::AID-ANR6>3.0.CO;2-E. [PubMed]

125. Maetzel A, Makela M, Hawker G, Bombardier C. Osteoarthritis of the hip and knee and mechanical occupational exposure-a systematic overview of the evidence. J Rheumatol. 1997;24:1599–1607. [PubMed]

126. Mannoni A, Briganti MP, Di Bari M, et al. Epidemiological profile of symptomatic osteoarthritis in older adults: a population based study in Dicomano, Italy. Ann Rheum Dis. 2003;62:576–578.[PMC free article] [PubMed]

127. Marks R, Allegrante JP. Body mass indices in patients with disabling hip osteoarthritis. Arthritis Res.2002;4:112–116. [PMC free article] [PubMed]

128. Mathias S, Nayak US, Isaacs B. Balance in elderly patients: the “get-up and go” test. Arch Phys Med Rehabil. 1986;67:387–389. [PubMed]

129. Matles AL. Motion of the hip joint. Bull Hosp Joint Dis. 1975;36:170–176. [PubMed]

130. McAlindon T. Why are clinical trials of glucosamine no longer uniformly positive? Rheum Dis Clin North Am. 2003;29:789–801. [PubMed]

131. McAlindon T, Formica M, LaValley M, Lehmer M, Kabbara K. Effectiveness of glucosamine for symptoms of knee osteoarthritis: results from an internet-based randomized double-blind controlled trial. Am J Med. 2004;117:643–649. http://dx.doi.org/10.1016/j.amjmed.2004.06.023. [PubMed]

132. McAlindon TE, LaValley MP, Gulin JP, Felson DT. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMA. 2000;283:1469–1475. [PubMed]

133. McGibbon CA, Krebs DE, Mann RW. In vivo hip pressures during cane and load-carrying gait.Arthritis Care Res. 1997;10:300–307. [PubMed]

134. McGibbon CA, Krebs DE, Scarborough DM. Rehabilitation effects on compensatory gait mechanics in people with arthritis and strength impairment. Arthritis Rheum. 2003;49:248–254.http://dx.doi.org/10.1002/art.11005. [PubMed]

135. Minor MA, Hewett JE, Webel RR, Anderson SK, Kay DR. Efficacy of physical conditioning exercise in patients with rheumatoid arthritis and osteoarthritis. Arthritis Rheum. 1989;32:1396–1405. [PubMed]

136. Minor MA, Hewett JE, Webel RR, Dreisinger TE, Kay DR. Exercise tolerance and disease related measures in patients with rheumatoid arthritis and osteoarthritis. J Rheumatol. 1988;15:905–911. [PubMed]

137. Mitchell B, McCrory P, Brukner P, O'Donnell J, Colson E, Howells R. Hip joint pathology: clinical presentation and correlation between magnetic resonance arthrography, ultrasound, and arthroscopic findings in 25 consecutive cases. Clin J Sport Med. 2003;13:152–156. [PubMed]

138. Murphy WA, Jr, Altman RD. Updated osteoarthritis reference standard. J Rheumatol Suppl.1995;43:56–59. [PubMed]

139. Nagasawa F, Miyake Y, Akazawa H, et al. Predictability of the progress of secondary osteoarthritis after developmental dislocation of the hip, utilizing inferior edge (of the teardrop)-center (of the femoral head) distance. J Orthop Sci. 2000;5:10–17. [PubMed]

140. Nahoda J. Difference of lower limb length in coxarthrosis. Ada Chir Orthop Traumatol Cech.1977;44:218–220. [PubMed]

141. Nahoda J. Significance of timely correction of leg length inequality in the prevention of osteoarthroses.Beitr Rheumatol. 1972;18:146–148. [PubMed]

142. Neumann DA. Biomechanical analysis of selected principles of hip joint protection. Arthritis Care Res.1989;2:146–155. [PubMed]

143. Neumann DA, Cook TM. Effect of load and carrying position on the electromyographic activity of the gluteus medius muscle during walking. Phys Ther. 1985;65:305–311. [PubMed]

144. Nevitt MC. Definition of hip osteoarthritis for epidemiological studies. Ann Rheum Dis. 1996;55:652–655. [PMC free article] [PubMed]

145. O’Connor MI. Sex differences in osteoarthritis of the hip and knee. J Am Acad Orthop Surg.2007;15(Suppl 1):S22–S25. [PubMed]

146. Oostendorp RA, vanden Heuvel JH, Dekker J, van Baar ME. Exercise therapy in patients with osteoarthritis of knee or hip: a protocol. Amersfoort/Utrecht: The Netherlands: NPI/NIVEL; 1998.

147. Palmoski MJ, Brandt KD. Proteoglycan depletion, rather than fibrillation, determines the effects of salicylate and indomethacin on osteoarthritic cartilage. Arthritis Rheum. 1985;28:548–553. [PubMed]

148. Pearson JR, Riddell DM. Idiopathic osteo-arthritis of the hip. Ann Rheum Dis. 1962;21:31–39.[PMC free article] [PubMed]

149. Perera S, Mody SH, Woodman RC, Studenski SA. Meaningful change and responsiveness in common physical performance measures in older adults. J Am Geriatr Soc. 2006;54:743–749.http://dx.doi.org/10.1111/j.1532-5415.2006.00701.x. [PubMed]

150. Pisters MF, Veenhof C, van Meeteren NL, et al. Long-term effectiveness of exercise therapy in patients with osteoarthritis of the hip or knee: a systematic review. Arthritis Rheum. 2007;57:1245–1253.http://dx.doi.org/10.1002/art.23009. [PubMed]

151. Podsiadlo D, Richardson S. The timed “Up & Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39:142–148. [PubMed]

152. Pua YH, Wrigley TV, Cowan SM, Bennell KL. Intrarater test-retest reliability of hip range of motion and hip muscle strength measurements in persons with hip osteoarthritis. Arch Phys Med Rehabil.2008;89:1146–1154. http://dx.doi.org/10.1016/j.apmr.2007.10.028. [PubMed]

153. Puett DW, Griffin MR. Published trials of nonmedicinal and noninvasive therapies for hip and knee osteoarthritis. Ann Intern Med. 1994;121:133–140. [PubMed]

154. Quintana JM, Arostegui I, Escobar A, Azkarate J, Goenaga JI, Lafuente I. Prevalence of knee and hip osteoarthritis and the appropriateness of joint replacement in an older population. Arch Intern Med.2008;168:1576–1584. http://dx.doi.org/10.1001/archinte.168.14.1576. [PubMed]

155. Qvistgaard E, Christensen R, Torp-Pedersen S, Bliddal H. Intra-articular treatment of hip osteoarthritis: a randomized trial of hyaluronic acid, corticosteroid, and isotonic saline. Osteoarthritis Cartilage.2006;14:163–170. http://dx.doi.org/10.1016/j.joca.2005.09.007. [PubMed]

156. Rasch A, Bystrom AH, Dalen N, Berg HE. Reduced muscle radiological density, cross-sectional area, and strength of major hip and knee muscles in 22 patients with hip osteoarthritis. Ada Orthop. 2007;78:505–510. http://dx.doi.org/10.1080/17453670710014158. [PubMed]

157. Ravaud P, Giraudeau B, Logeart I, et al. Management of osteoarthritis (OA) with an unsupervised home based exercise programme and/or patient administered assessment tools. A cluster randomised controlled trial with a 2×2 factorial design. Ann Rheum Dis. 2004;63:703–708.http://dx.doi.org/10.1136/ard.2003.009803. [PMC free article] [PubMed]

158. Reichenbach S, Sterchi R, Scherer M, et al. Meta-analysis: chondroitin for osteoarthritis of the knee or hip. Ann Intern Med. 2007;146:580–590. [PubMed]

159. Reijman M, Bierma-Zeinstra SM, Pols HA, Koes BW, Strieker BH, Hazes JM. Is there an association between the use of different types of nonsteroidal antiinflammatory drugs and radiologic progression of osteoarthritis? The Rotterdam Study. Arthritis Rheum. 2005;52:3137–3142.http://dx.doi.org/10.1002/art.21357. [PubMed]

160. Reijman M, Hazes JM, Pols HA, Bernsen RM, Koes BW, Bierma-Zeinstra SM. Role of radiography in predicting progression of osteoarthritis of the hip: prospective cohort study. BMJ. 2005;330:1183.[PMC free article] [PubMed]

161. Reijman M, Pols HA, Bergink AP, et al. Body mass index associated with onset and progression of osteoarthritis of the knee but not of the hip: the Rotterdam Study. Ann Rheum Dis. 2007;66:158–162.http://dx.doi.org/10.1136/ard.2006.053538. [PMC free article] [PubMed]

162. Reikeras O, Bjerkreim I, Kolbenstvedt A. Anteversion of the acetabulum and femoral neck in normals and in patients with osteoarthritis of the hip. Acfa Orthop Scand. 1983;54:18–23. [PubMed]

163. Robinson P, Keenan AM, Conaghan PG. Clinical effectiveness and dose response of image-guided intra-articular corticosteroid injection for hip osteoarthritis. Rheumatology (Oxford) 2007;46:285–291.http://dx.doi.org/10.1093/rheumatology/kel217. [PubMed]

164. Roddy E, Zhang W, Doherty M, et al. Evidence-based recommendations for the role of exercise in the management of osteoarthritis of the hip or knee-the MOVE consensus. Rheumatology (Oxford) 2005;44:67–73. [PubMed]

165. Rooks DS, Huang J, Bierbaum BE, et al. Effect of preoperative exercise on measures of functional status in men and women undergoing total hip and knee arthroplasty. Arthritis Rheum. 2006;55:700–708.http://dx.doi.org/10.1002/art.22223. [PubMed]

166. Roos EM, Klassbo M, Lohmander LS. WOMAC osteoarthritis index. Reliability, validity, and responsiveness in patients with arthroscopically assessed osteoarthritis. Western Ontario and MacMaster Universities. Scand J Rheumatol. 1999;28:210–215. [PubMed]

167. Salaffi F, Carotti M, Stancati A, Grassi W. Radiographic assessment of osteoarthritis: analysis of disease progression. Aging Clin Exp Res. 2003;15:391–404. [PubMed]

168. Singleton MC, LeVeau BF. The hip joint: structure, stability, and stress; a review. Phys Ther.1975;55:957–973. [PubMed]

169. Soderman P, Malchau H. Validity and reliability of Swedish WOMAC osteoarthritis index: a self-administered disease-specific questionnaire (WOMAC) versus generic instruments (SF-36 and NHP) Acta Orthop Scand. 2000;71:39–46. http://dx.doi.org/10.1080/00016470052943874. [PubMed]

170. Steffen TM, Hacker TA, Mollinger L. Age- and gender-related test performance in community-dwelling elderly people: Six-Minute Walk Test, Berg Balance Scale, Timed Up & Go Test, and gait speeds.Phys Ther. 2002;82:128–137. [PubMed]

171. Steultjens MP, Dekker J, van Baar ME, Oostendorp RA, Bijlsma JW. Muscle strength, pain and disability in patients with osteoarthritis. Clin Rehabil. 2001;15:331–341. [PubMed]

172. Steultjens MP, Dekker J, van Baar ME, Oostendorp RA, Bijlsma JW. Range of joint motion and disability in patients with osteoarthritis of the knee or hip. Rheumatology (Oxford) 2000;39:955–961.[PubMed]

173. Sturnieks DL, Tiedemann A, Chapman K, Munro B, Murray SM, Lord SR. Physiological risk factors for falls in older people with lower limb arthritis. J Rheumatol. 2004;31:2272–2279. [PubMed]

174. Superio-Cabuslay E, Ward MM, Lorig KR. Patient education interventions in osteoarthritis and rheumatoid arthritis: a meta-analytic comparison with nonsteroidal antiinflammatory drug treatment. Arthritis Care Res. 1996;9:292–301. [PubMed]

175. Sutlive TG, Lopez HP, Schnitker DE, et al. Development of a clinical prediction rule for diagnosing hip osteoarthritis in individuals with unilateral hip pain. J Orthop Sports Phys Ther. 2008;38:542–550.http://dx.doi.org/10.2519/jospt.2008.2753. [PubMed]

176. Tak E, Staats P, Van Hespen A, Hopman-Rock M. The effects of an exercise program for older adults with osteoarthritis of the hip. J Rheumatol. 2005;32:1106–1113. [PubMed]

177. Tepper S, Hochberg MC. Factors associated with hip osteoarthritis: data from the First National Health and Nutrition Examination Survey (NHANES-I) Am J Epidemiol. 1993;137:1081–1088. [PubMed]

178. Terjesen T, Benum P, Anda S, Svenningsen S. Increased femoral anteversion and osteoarthritis of the hip joint. Acta Orthop Scand. 1982;53:571–575. [PubMed]

179. Thelin A. Hip joint arthrosis: an occupational disorder among farmers. Am J Ind Med. 1990;18:339–343. [PubMed]

180. Thelin A, Holmberg S. Hip osteoarthritis in a rural male population: A prospective population-based register study. Am J Ind Med. 2007;50:604–607. http://dx.doi.org/10.1002/ajim.20484. [PubMed]

181. Thelin A, Jansson B, Jacobsson B, Strom H. Coxarthrosis and farm work: a case-referent study. Am J Ind Med. 1997;32:497–501. http://dx.doi.org/10.1002/(SICI)1097-0274(199711)32:5<497::AID-AJIM9>3.0.CO;2-P [pii] [PubMed]

182. Thelin A, Vingard E, Holmberg S. Osteoarthritis of the hip joint and farm work. Am J Ind Med.2004;45:202–209. http://dx.doi.org/10.1002/ajim.10330. [PubMed]

183. Thumboo J, Chew LH, Soh CH. Validation of the Western Ontario and Mcmaster University osteoarthritis index in Asians with osteoarthritis in Singapore. Osteoarthritis Cartilage. 2001;9:440–446.http://dx.doi.org/10.1053/joca.2000.0410. [PubMed]

184. Tokuhashi Y, Matsuzaki H, Uematsu Y, Oda H. Symptoms of thoracolum-bar junction disc herniation.Spine. 2001;26:E512–E518. [PubMed]

185. Tonnis D, Heinecke A. Acetabular and femoral anteversion: relationship with osteoarthritis of the hip. J Bone Joint Surg Am. 1999;81:1747–1770. [PubMed]

186. Tonnis D, Heinecke A. Decreased acetabular anteversion and femur neck antetorsion cause pain and arthrosis. 1: Statistics and clinical sequelae. Z Orthop Ihre Grenzgeb. 1999;137:153–159. [PubMed]

187. Tonnis D, Heinecke A. Decreased acetabular anteversion and femur neck antetorsion cause pain and arthrosis. 2: Etiology, diagnosis and therapy. Z Orthop Ihre Grenzgeb. 1999;137:160–167. [PubMed]

188. Tonnis D, Heinecke A. Diminished femoral antetorsion syndrome: a cause of pain and osteoarthritis. J Pediatr Orthop. 1991;11:419–431. [PubMed]

189. Towheed TE, Hochberg MC. A systematic review of randomized controlled trials of pharmacological therapy in osteoarthritis of the hip. J Rheumatol. 1997;24:349–357. [PubMed]

190. van Baar ME, Assendelft WJ, Dekker J, Oostendorp RA, Bijlsma JW. Effectiveness of exercise therapy in patients with osteoarthritis of the hip or knee: a systematic review of randomized clinical trials. Arthritis Rheum. 1999;42:1361–1369. http://dx.doi.org/10.1002/1529-0131(199907)42:7<1361::AID-ANR9>3.0.CO;2-9. [PubMed]

191. van Baar ME, Dekker J, Lemmens JA, Oostendorp RA, Bijlsma JW. Pain and disability in patients with osteoarthritis of hip or knee: the relation-ship with articular, kinesiological, and psychological characteristics.J Rheumatol. 1998;25:125–133. [PubMed]

192. van Baar ME, Dekker J, Oostendorp RA, Bijl D, Voorn TB, Bijlsma JW. Effectiveness of exercise in patients with osteoarthritis of hip or knee: nine months’ follow up. Ann Rheum Dis. 2001;60:1123–1130.[PMC free article] [PubMed]

193. van Baar ME, Dekker J, Oostendorp RA, et al. The effectiveness of exercise therapy in patients with osteoarthritis of the hip or knee: a randomized clinical trial. J Rheumatol. 1998;25:2432–2439. [PubMed]

194. van den Bekerom MP, Lamme B, Sermon A, Mulier M. What is the evidence for viscosupplementation in the treatment of patients with hip osteoarthritis? Systematic review of the literature. Arch Orthop Trauma Surg. 2008;128:815–823. http://dx.doi.org/10.1007/s00402-007-0447-z. [PubMed]

195. van den Bekerom MP, Rys B, Mulier M. Viscosupplementation in the hip: evaluation of hyaluronic acid formulations. Arch Orthop Trauma Surg. 2008;128:275–280. http://dx.doi.org/10.1007/s00402-007-0374-z. [PMC free article] [PubMed]

196. Van der Esch M, Heijmans M, Dekker J. Factors contributing to possession and use of walking aids among persons with rheumatoid arthritis and osteoarthritis. Arthritis Rheum. 2003;49:838–842.http://dx.doi.org/10.1002/art.11463. [PubMed]

197. van Dijk GM, Veenhof C, Schellevis F, et al. Comorbidity limitations in activities and pain in patients with osteoarthritis of the hip or knee. BMC Musculoskelet Disord. 2008;9:95.http://dx.doi.org/10.1186/1471-2474-9-95. [PMC free article] [PubMed]

198. Villanueva I, del Mar Guzman M, Javier Toyos F, Ariza-Ariza R, Navarro F. Relative efficiency and validity properties of a visual analogue vs a categorical scaled version of the Western Ontario and McMaster Universities Osteoarthritis (WOMAC) Index: Spanish versions. Osteoarthritis Cartilage. 2004;12:225–231.http://dx.doi.org/10.1016/j.joca.2003.11.006. [PubMed]

199. Vinciguerra C, Gueguen A, Revel M, Heuleu JN, Amor B, Dougados M. Predictors of the need for total hip replacement in patients with osteoarthritis of the hip. Rev Rhum Engl. Ed. 1995;62:563–570.[PubMed]

200. Vingard E. Overweight predisposes to coxarthrosis. Body-mass index studied in 239 males with hip arthroplasty. Ada Orthop Scand. 1991;62:106–109. [PubMed]

201. Vingard E, Alfredsson L, Goldie I, Hogstedt C. Occupation and osteoarthrosis of the hip and knee: a register-based cohort study. Int J Epidemiol. 1991;20:1025–1031. [PubMed]

202. Vingard E, Alfredsson L, Malchau H. Lifestyle factors and hip arthrosis. A case referent study of body mass index, smoking and hormone therapy in 503 Swedish women. Ada Orthop Scand. 1997;68:216–220.[PubMed]

203. Vingard E, Alfredsson L, Malchau H. Osteoarthrosis of the hip in women and its relation to physical load at work and in the home. Ann Rheum Dis. 1997;56:293–298. [PMC free article] [PubMed]

204. Vingard E, Hogstedt C, Alfredsson L, Fellenius E, Goldie I, Koster M. Coxarthrosis and physical work load. Scand J Work Environ Health. 1991;17:104–109. [PubMed]

205. Vlad SC, LaValley MP, McAlindon TE, Felson DT. Arthritis Rheum. 2007;56:2267–2277.http://dx.doi.org/10.1002/art.22728. [PubMed]

206. Vossinakis IC, Georgiades G, Kafidas D, Hartofilakidis G. Unilateral hip osteoarthritis: can we predict the outcome of the other hip? Skeletal Radiol. 2008;37:911–916. http://dx.doi.org/10.1007/s00256-008-0522-8. [PubMed]

207. Vossinakis LC, Karnezis LA, Parry K, Learmonth ID. Radiographic associations for “primary” hip osteoarthrosis: a retrospective cohort study of 47 patients. Ada Orthop Scand. 2001;72:600–608.http://dx.doi.org/10.1080/000164701317269021. [PubMed]

208. Walker-Bone K, Palmer KT. Musculoskeletal disorders in farmers and farm workers. Occup Med (Lond) 2002;52:441–450. [PubMed]

209. World Health Organization. International Classification of Disease. ICD-10. Geneva: Switzerland; 2005.

210. World Health Organization. International Classification of Functioning, Disability, and Health. Geneva: Switzerland; 2001.

211. Xu L, Nevitt MC, Zhang Y, Yu W, Alibadi P, Felson DT. High prevalence of knee, but not hip or hand osteoarthritis in Beijing elders: comparison with data of Caucasian in United States. Zhonghua Yi Xue Za Zhi. 2003;83:1206–1209. [PubMed]

212. Yang KG, Raijmakers NJ, Verbout AJ, Dhert WJ, Saris DB. Validation of the short-form WOMAC function scale for the evaluation of osteoarthritis of the knee. J Bone Joint Surg Br. 2007;89:50–56.http://dx.doi.org/10.1302/0301-620X.89B1.17790. [PubMed]

213. Youdas JW, Mraz ST, Norstad BJ, Schinke JJ, Hollman JH. Determining meaningful changes in hip abductor muscle strength obtained by hand-held dynamometry. Physiother Theory Pract. 2008;24:215–220.http://dx.doi.org/10.1080/03639040701429374. [PubMed]

214. Yrjonen T. Long-term prognosis of Legg-Calve-Perthes disease: a meta-analysis. J Pediatr Orthop B.1999;8:169–172. [PubMed]

215. Zhang W, Doherty M, Arden N, et al. EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) Ann Rheum Dis. 2005;64:669–681.http://dx.doi.org/10.1136/ard.2004.028886. [PMC free article] [PubMed]

216. Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthritis Cartilage. 2007;15:981–1000. http://dx.doi.org/10.1016/j.joca.2007.06.014.[PubMed]